Signaling Pathway Analyses
Organism Code: dre
Signaling Pathway File Creation Date: 03/16/22
Pathway DB Name: REACTOME
Deduplicate Gene Sets: false
Data Source: DES_DeSeq_normDataF2
Work Source: DES_DeSeq_normDataF2_williams_0.05_NOMTC_foldfilter1.5_BMD
BMDExpress3 Version: BMDExpress 3.00.0020 BETA
Timestamp (Start Time): 04/27/2022 18:45.17
Remove Promiscuous Probes: true
Remove BMD > Highest Dose from Category Descriptive Statistics: true
Remove BMD with p-Value < Cutoff: 0.1
Remove genes with BMD/BMDL >: 20.0
Remove genes with BMDU/BMDL >: 40.0
Remove genes with BMDU/BMD >: 20.0
Remove genes with BMD values > N fold below the lowest positive does: 10.0
Identify conflicting probe sets: 0.5
Category Count: 768
Total Run Time: 18 seconds

GO/Pathway/Gene Set/Gene ID	GO/Pathway/Gene Set/Gene Name	All Genes (Expression Data)	All Genes (Platform)	Input Genes	Genes with BMD <= Highest Dose	Genes with BMD p-Value >= 	Genes with BMD/BMDL <= 	Genes with BMDU/BMD <= 	Genes with BMDU/BMDL <= 	Genes with BMD <= N-Fold Lowest Positive Dose 	Genes That Passed All Filters	Fisher's A Parameter	Fisher's B Parameter	Fisher's C Parameter	Fisher's D Parameter	Fisher's Exact Left P-Value	Fisher's Exact Right P-Value	Fisher's Exact Two Tail	Percentage	Entrez Gene IDs	Gene Symbols	Probe IDs	Genes with Conflicting Probesets	BMD Mean	BMD Median	BMD Minimum	BMD Standard Deviation	BMD wMean	BMD wSD	BMDL Mean	BMDL Median	BMDL Minimum	BMDL Standard Deviation	BMDL wMean	BMDL wSD	BMDU Mean	BMDU Median	BMDU Minimum	BMDU Standard Deviation	BMDU wMean	BMDU wSD	5th Percentile Index	BMD at 5th Percentile of Total Genes	10th Percentile Index	BMD at 10th Percentile of Total Genes	BMD List	BMDL List	BMDU List	Probes with Adverse Direction Up	Probes with Adverse Direction Down	Genes with Adverse Direction Up	Genes Up List	Genes Up Probes List	Genes Up BMD Mean	Genes Up BMD Median	Genes Up SD	Genes Up BMDL Mean	Genes Up BMDL Median	Genes Up BMDL SD	Genes Up BMDU Mean	Genes Up BMDU Median	Genes Up BMDU SD	BMD list (up)	BMDL List (up)	BMDU List (up)	Genes with Adverse Direction Down	Genes Down List	Genes Down Probes List	Genes Down BMD Mean	Genes Down BMD Median	Genes Down SD	Genes Down BMDL Mean	Genes Down BMDL Median	Genes Down BMDL SD	Genes Down BMDU Mean	Genes Down BMDU Median	Genes Down BMDU SD	BMD list (down)	BMDL List (down)	BMDU List (down)	Genes with Adverse Conflict Count	Genes Conflict List	Genes Conflict Probes List	BMD list (Conflict)	BMDL list (Conflict)	BMDU list (Conflict)	Model Counts	Mean Fold Change	Total Fold Change	Min Fold Change	Max Fold Change	Standard Deviation Fold Change	Median Fold Change	Lower bound of the 95% confidence interval -  BMD	Upper bound of the 95% confidence interval -  BMD	Lower bound of the 95% confidence interval -  BMDL	Upper bound of the 95% confidence interval -  BMDL	Lower bound of the 95% confidence interval -  BMDU	Upper bound of the 95% confidence interval -  BMDU	Overall Direction	Percent Genes With Overall Direction Up	Percent Genes With Overall Direction Down	Percent Genes With Overall Direction Conflict
R-DRE-109582	Hemostasis	220	307	18	10	4	16	16	14	18	3	3	26	304	4559	0.89503	0.27282	0.42463	0.98	767657;553656;553553	abhd12;hrasb;cfd	ENSDARG00000071004;ENSDARG00000005651;ENSDARG00000039579		61.60253333333333	58.5336	41.759	21.54257755825276	55.90997870527336	21.49192244442262	29.171166666666664	29.7061	24.7404	4.188995362056818	27.873805576815826	4.341118782313043	133.94320000000002	115.336	70.4846	74.52522168849949	115.92821291800776	72.9170003226317					84.515;41.759;58.5336	33.067;24.7404;29.7061	216.009;70.4846;115.336	1	2	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	2	767657;553553	ENSDARG00000071004;ENSDARG00000039579	71.5243	71.5243	18.371624124720242	31.38655	31.38655	2.376515180889902	165.67249999999999	165.67249999999999	71.18656098239335	84.515;58.5336	33.067;29.7061	216.009;115.336	0						Linear,3(1)	2.501510331914322	8.087645411491394	1.672296166419983	4.171412944793701	1.3094224763701832	2.24393630027771	37.22481194683397	85.9802547198327	24.430872170828202	33.911461162505134	49.60997266558738	218.2764273344126	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-114608	Platelet degranulation 	48	69	5	3	1	5	5	5	5	1	1	28	68	4795	0.93765	0.33843	0.33843	1.45	553553	cfd	ENSDARG00000039579		58.5336	58.5336	58.5336		58.5336		29.7061	29.7061	29.7061		29.7061		115.336	115.336	115.336		115.33599999999998						58.5336	29.7061	115.336	0	1	0															1	553553	ENSDARG00000039579	58.5336	58.5336		29.7061	29.7061		115.336	115.336		58.5336	29.7061	115.336	0						Linear,1(1)	1.672296166419983	1.672296166419983	1.672296166419983	1.672296166419983	0.0	1.672296166419983	58.5336	58.5336	29.7061	29.7061	115.336	115.336	DOWN	0.0	1.0	0.0	
R-DRE-168249	Innate Immune System	383	502	29	17	7	25	25	19	29	4	4	25	498	4365	0.82952	0.34675	0.53273	0.8	792922;553656;553553;437015	si:ch211-160j14.2;hrasb;cfd;trappc1	ENSDARG00000073961;ENSDARG00000005651;ENSDARG00000039579;ENSDARG00000039005		38.265605	46.50965	1.50952	25.448427015019345	17.896385652169634	26.032470721773144	20.655417749999998	26.304850000000002	0.305871	13.720375106881264	9.608797352560957	14.605056851893401	71.8884675	82.3841	7.44967	46.70317443612967	35.36581612173654	45.35824409515859					1.50952;41.759;58.5336;51.2603	0.305871;24.7404;29.7061;27.8693	7.44967;70.4846;115.336;94.2836	1	3	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	3	792922;553553;437015	ENSDARG00000073961;ENSDARG00000039579;ENSDARG00000039005	37.10114	51.2603	31.037038903394127	19.293757	27.8693	16.469618077592052	72.35642333333334	94.2836	57.18798700466411	1.50952;58.5336;51.2603	0.305871;29.7061;27.8693	7.44967;115.336;94.2836	0						Exp 3,1(0.25);Linear,3(0.75)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	2.921854555606842	13.326146525281029	63.205063474718955	7.209450145256369	34.101385354743634	26.119356552592897	117.6575784474071	DOWN	0.25	0.75	0.0	
R-DRE-168256	Immune System	594	839	45	29	12	38	38	28	45	5	5	24	834	4029	0.62168	0.57165	1.0	0.6	792922;553656;553553;437015;378451	si:ch211-160j14.2;hrasb;cfd;trappc1;fbxl3a	ENSDARG00000073961;ENSDARG00000005651;ENSDARG00000039579;ENSDARG00000039005;ENSDARG00000103505		38.886764	41.759	1.50952	22.08270863527571	21.587220006956397	25.03436423345528	21.4447542	24.7404	0.305871	12.012567584061207	11.966103537040365	14.344636194185485	71.42497399999999	70.4846	7.44967	40.45941185844625	40.743690056086706	42.653494330802495					1.50952;41.759;58.5336;51.2603;41.3714	0.305871;24.7404;29.7061;27.8693;24.6021	7.44967;70.4846;115.336;94.2836;69.571	2	3	2	553656;378451	ENSDARG00000005651;ENSDARG00000103505	41.565200000000004	41.565200000000004	0.274074588386654	24.67125	24.67125	0.09779286783765195	70.0278	70.0278	0.6460127552930188	41.759;41.3714	24.7404;24.6021	70.4846;69.571	3	792922;553553;437015	ENSDARG00000073961;ENSDARG00000039579;ENSDARG00000039005	37.10114	51.2603	31.037038903394127	19.293757	27.8693	16.469618077592052	72.35642333333334	94.2836	57.18798700466411	1.50952;58.5336;51.2603	0.305871;29.7061;27.8693	7.44967;115.336;94.2836	0						Exp 3,1(0.2);Linear,4(0.8)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	3.3780648708343506	19.530416446767145	58.243111553232836	10.915274460709659	31.974233939290343	35.96073586390243	106.88921213609758	DOWN	0.4	0.6	0.0	
R-DRE-6798695	Neutrophil degranulation	228	300	17	11	4	15	15	12	17	3	3	26	297	4566	0.90157	0.26137	0.42007	1.0	792922;553553;437015	si:ch211-160j14.2;cfd;trappc1	ENSDARG00000073961;ENSDARG00000039579;ENSDARG00000039005		37.10114	51.2603	1.50952	31.037038903394127	12.540007733174836	26.43431197276884	19.293757	27.8693	0.305871	16.469618077592052	6.212246533848377	14.122291334736254	72.35642333333334	94.2836	7.44967	57.18798700466411	27.482795604138293	48.22452141461556					1.50952;58.5336;51.2603	0.305871;29.7061;27.8693	7.44967;115.336;94.2836	0	3	0															3	792922;553553;437015	ENSDARG00000073961;ENSDARG00000039579;ENSDARG00000039005	37.10114	51.2603	31.037038903394127	19.293757	27.8693	16.469618077592052	72.35642333333334	94.2836	57.18798700466411	1.50952;58.5336;51.2603	0.305871;29.7061;27.8693	7.44967;115.336;94.2836	0						Exp 3,1(0.34);Linear,2(0.67)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	NaN	1.9794241791819758	72.22285582081803	0.6566296761257284	37.93088432387427	7.64212393788425	137.0707227287824	DOWN	0.0	1.0	0.0	
R-DRE-76002	Platelet activation, signaling and aggregation	99	141	9	6	2	9	9	9	9	2	2	27	139	4724	0.95041	0.20303	0.20303	1.42	767657;553553	abhd12;cfd	ENSDARG00000071004;ENSDARG00000039579		71.5243	71.5243	58.5336	18.371624124720242	72.12510707406143	18.35196541789235	31.38655	31.38655	29.7061	2.376515180889902	31.464269156597144	2.373972171360865	165.67249999999999	165.67249999999999	115.336	71.18656098239335	168.00051352378952	71.11038721991413					84.515;58.5336	33.067;29.7061	216.009;115.336	0	2	0															2	767657;553553	ENSDARG00000071004;ENSDARG00000039579	71.5243	71.5243	18.371624124720242	31.38655	31.38655	2.376515180889902	165.67249999999999	165.67249999999999	71.18656098239335	84.515;58.5336	33.067;29.7061	216.009;115.336	0						Linear,2(1)	1.937143792454513	3.916232466697693	1.672296166419983	2.24393630027771	0.40421061504918454	1.9581162333488464	46.062528	96.986072	28.092868	34.680232000000004	67.01296	264.33203999999995	DOWN	0.0	1.0	0.0	
R-DRE-76005	Response to elevated platelet cytosolic Ca2+	50	71	5	3	1	5	5	5	5	1	1	28	70	4793	0.93443	0.34636	0.34636	1.41	553553	cfd	ENSDARG00000039579		58.5336	58.5336	58.5336		58.5336		29.7061	29.7061	29.7061		29.7061		115.336	115.336	115.336		115.33599999999998						58.5336	29.7061	115.336	0	1	0															1	553553	ENSDARG00000039579	58.5336	58.5336		29.7061	29.7061		115.336	115.336		58.5336	29.7061	115.336	0						Linear,1(1)	1.672296166419983	1.672296166419983	1.672296166419983	1.672296166419983	0.0	1.672296166419983	58.5336	58.5336	29.7061	29.7061	115.336	115.336	DOWN	0.0	1.0	0.0	
R-DRE-1430728	Metabolism	815	1029	49	34	14	37	37	30	49	6	6	23	1023	3840	0.58903	0.59153	1.0	0.58	561810;554095;553384;436914;403031;402943	dnph1;fabp1b.1;cox10;acss2;rab4a;stard10	ENSDARG00000075730;ENSDARG00000059227;ENSDARG00000034309;ENSDARG00000037781;ENSDARG00000019144;ENSDARG00000097718		48.69823766666667	50.74695	0.201926	30.27227668928969	48.34929284673477	25.68238919733993	23.7106158	27.6036	0.0364948	12.134545727460663	24.57622451782317	10.128172630438733	104.03314166666667	93.62275	1.11725	84.4370302592436	98.50795085828791	72.2594253578064					92.0486;60.5176;57.335;37.9274;0.201926;44.1589	33.5239;30.1468;29.5537;23.3493;0.0364948;25.6535	252.744;121.485;111.232;61.6071;1.11725;76.0135	3	3	3	554095;436914;402943	ENSDARG00000059227;ENSDARG00000037781;ENSDARG00000097718	47.53463333333334	44.1589	11.667303272964702	26.3832	25.6535	3.456999874168376	86.36853333333333	76.0135	31.25317205666227	60.5176;37.9274;44.1589	30.1468;23.3493;25.6535	121.485;61.6071;76.0135	3	561810;553384;403031	ENSDARG00000075730;ENSDARG00000034309;ENSDARG00000019144	49.861841999999996	57.335	46.377138215777094	21.0380316	29.5537	18.29587475310529	121.69775	111.232	126.13942393711612	92.0486;57.335;0.201926	33.5239;29.5537;0.0364948	252.744;111.232;1.11725	0						Hill,1(0.17);Linear,5(0.84)	Infinity	Infinity	1.5967966318130493	Infinity	NaN	2.4840972423553467	24.475371461237586	72.92110387209574	14.000957004368876	33.42027459563112	36.4694460865106	171.59683724682273	CONFLICT	0.5	0.5	0.0	
R-DRE-156580	Phase II - Conjugation of compounds	44	48	3	2	1	3	3	2	3	0	0	29	48	4815	0.75068	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211859	Biological oxidations	97	112	8	7	3	8	8	6	8	1	1	28	111	4752	0.85836	0.49014	0.49014	0.89	436914	acss2	ENSDARG00000037781		37.9274	37.9274	37.9274		37.9274		23.3493	23.3493	23.3493		23.3493		61.6071	61.6071	61.6071		61.6071						37.9274	23.3493	61.6071	1	0	1	436914	ENSDARG00000037781	37.9274	37.9274		23.3493	23.3493		61.6071	61.6071		37.9274	23.3493	61.6071	0															0						Linear,1(1)	1.7204608917236328	1.7204608917236328	1.7204608917236328	1.7204608917236328	0.0	1.7204608917236328	37.9274	37.9274	23.3493	23.3493	61.6071	61.6071	UP	1.0	0.0	0.0	
R-DRE-15869	Metabolism of nucleotides	47	54	2	1	1	2	2	1	2	1	1	28	53	4810	0.95985	0.2759	0.2759	1.85	561810	dnph1	ENSDARG00000075730		92.0486	92.0486	92.0486		92.0486		33.5239	33.5239	33.5239		33.5239		252.744	252.744	252.744		252.74399999999997						92.0486	33.5239	252.744	0	1	0															1	561810	ENSDARG00000075730	92.0486	92.0486		33.5239	33.5239		252.744	252.744		92.0486	33.5239	252.744	0						Linear,1(1)	2.877150297164917	2.877150297164917	2.877150297164917	2.877150297164917	0.0	2.877150297164917	92.0486	92.0486	33.5239	33.5239	252.744	252.744	DOWN	0.0	1.0	0.0	
R-DRE-8956321	Nucleotide salvage	14	14	1	0	0	1	1	0	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1266738	Developmental Biology	170	204	11	8	4	9	9	8	11	1	1	28	203	4660	0.6575	0.71029	1.0	0.49	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	52	73	4	1	0	4	4	2	4	0	0	29	73	4790	0.6458	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392499	Metabolism of proteins	795	976	54	34	17	41	41	30	54	6	6	23	970	3893	0.64561	0.53428	0.8197	0.61	559933;437015;403031;394141;378451;337461	pex14;trappc1;rab4a;dctn2;fbxl3a;nup35	ENSDARG00000028322;ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388;ENSDARG00000103505;ENSDARG00000012222		44.448771	46.31585	0.201926	28.2576993349311	39.63539784676588	24.319151695281914	22.6176158	26.2357	0.0364948	11.944660215778175	21.589209451186722	10.533799336247368	90.27444166666668	81.9273	1.11725	72.35574116985065	75.2206118023284	61.363641463958324					58.814;51.2603;0.201926;30.7771;41.3714;84.2679	29.9372;27.8693;0.0364948;20.0664;24.6021;33.1942	115.545;94.2836;1.11725;47.2048;69.571;213.925	2	4	2	559933;378451	ENSDARG00000028322;ENSDARG00000103505	50.0927	50.0927	12.33378074152446	27.26965	27.26965	3.772485388308397	92.55799999999999	92.55799999999999	32.50852715827042	58.814;41.3714	29.9372;24.6021	115.545;69.571	4	437015;403031;394141;337461	ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388;ENSDARG00000012222	41.6268065	41.0187	35.33083595324678	20.2915987	23.96785	14.53981459938033	89.13266250000001	70.7442	91.47735265664917	51.2603;0.201926;30.7771;84.2679	27.8693;0.0364948;20.0664;33.1942	94.2836;1.11725;47.2048;213.925	0						Hill,1(0.17);Linear,5(0.84)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	2.8609853982925415	21.83790240598217	67.05963959401782	13.059897058004216	32.17533454199579	32.37779069650562	148.17109263682772	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-597592	Post-translational protein modification	594	751	43	25	13	33	33	25	43	6	6	23	745	4118	0.85482	0.27998	0.43531	0.8	559933;437015;403031;394141;378451;337461	pex14;trappc1;rab4a;dctn2;fbxl3a;nup35	ENSDARG00000028322;ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388;ENSDARG00000103505;ENSDARG00000012222		44.448771	46.31585	0.201926	28.2576993349311	39.63539784676588	24.319151695281914	22.6176158	26.2357	0.0364948	11.944660215778175	21.589209451186722	10.533799336247368	90.27444166666668	81.9273	1.11725	72.35574116985065	75.2206118023284	61.363641463958324					58.814;51.2603;0.201926;30.7771;41.3714;84.2679	29.9372;27.8693;0.0364948;20.0664;24.6021;33.1942	115.545;94.2836;1.11725;47.2048;69.571;213.925	2	4	2	559933;378451	ENSDARG00000028322;ENSDARG00000103505	50.0927	50.0927	12.33378074152446	27.26965	27.26965	3.772485388308397	92.55799999999999	92.55799999999999	32.50852715827042	58.814;41.3714	29.9372;24.6021	115.545;69.571	4	437015;403031;394141;337461	ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388;ENSDARG00000012222	41.6268065	41.0187	35.33083595324678	20.2915987	23.96785	14.53981459938033	89.13266250000001	70.7442	91.47735265664917	51.2603;0.201926;30.7771;84.2679	27.8693;0.0364948;20.0664;33.1942	94.2836;1.11725;47.2048;213.925	0						Hill,1(0.17);Linear,5(0.84)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	2.8609853982925415	21.83790240598217	67.05963959401782	13.059897058004216	32.17533454199579	32.37779069650562	148.17109263682772	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-8957275	Post-translational protein phosphorylation	46	60	3	0	0	3	3	1	3	0	0	29	60	4803	0.69843	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-109581	Apoptosis	56	71	3	2	0	3	3	3	3	0	0	29	71	4792	0.65364	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-109606	Intrinsic Pathway for Apoptosis	22	28	1	1	0	1	1	1	1	0	0	29	28	4835	0.84625	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111447	Activation of BAD and translocation to mitochondria 	11	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-114452	Activation of BH3-only proteins	15	15	1	1	0	1	1	1	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1227986	Signaling by ERBB2	23	27	3	2	1	3	3	3	3	1	1	28	26	4837	0.98913	0.14868	0.14868	3.7	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-1257604	PIP3 activates AKT signaling	113	159	10	6	3	6	6	6	10	0	0	29	159	4704	0.3825	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1280215	Cytokine Signaling in Immune system	134	205	11	7	4	6	6	5	11	0	0	29	205	4658	0.28791	1.0	0.63261	0.0																														0	0	0															0															0																							
R-DRE-1280218	Adaptive Immune System	247	364	21	13	6	17	17	12	21	2	2	27	362	4501	0.63243	0.64701	1.0	0.55	553656;378451	hrasb;fbxl3a	ENSDARG00000005651;ENSDARG00000103505		41.565200000000004	41.565200000000004	41.3714	0.274074588386654	41.56350421096713	0.27406409578670593	24.67125	24.67125	24.6021	0.09779286783765195	24.67064492357264	0.0977891239598723	70.0278	70.0278	69.571	0.6460127552930188	70.02380290799685	0.6459880235035376					41.759;41.3714	24.7404;24.6021	70.4846;69.571	2	0	2	553656;378451	ENSDARG00000005651;ENSDARG00000103505	41.565200000000004	41.565200000000004	0.274074588386654	24.67125	24.67125	0.09779286783765195	70.0278	70.0278	0.6460127552930188	41.759;41.3714	24.7404;24.6021	70.4846;69.571	0															0						Linear,2(1)	3.753838506189534	7.549477815628052	3.3780648708343506	4.171412944793701	0.5609818029379434	3.774738907814026	41.18535200000001	41.945048	24.535716	24.806784	69.13247199999999	70.923128	UP	1.0	0.0	0.0	
R-DRE-162582	Signal Transduction	917	1352	56	40	24	40	40	35	56	10	10	19	1342	3521	0.84958	0.26211	0.40853	0.74	80963;767657;751645;553656;550506;445170;436667;404604;403031;100005849	rnd3a;abhd12;rnd2;hrasb;nsmaf;polr2eb;b9d2;clasp2;rab4a;rhov	ENSDARG00000076799;ENSDARG00000071004;ENSDARG00000070735;ENSDARG00000005651;ENSDARG00000051920;ENSDARG00000026183;ENSDARG00000017385;ENSDARG00000020345;ENSDARG00000019144;ENSDARG00000070434		54.2038826	52.301950000000005	0.201926	25.423215627876758	52.269191112050464	19.492579426705188	25.321459479999998	27.381500000000003	0.0364948	9.666700157916754	25.889446231102184	7.492839483418555	120.295145	97.11930000000001	1.11725	73.66534586029525	108.99174547053055	58.0716823675335					72.0116;84.515;60.6068;41.759;40.6531;50.7841;48.2892;53.8198;0.201926;89.3983	32.056;33.067;22.0961;24.7404;24.4822;27.7952;26.9678;28.5511;0.0364948;33.4223	161.769;216.009;166.237;70.4846;67.5052;92.7866;86.4678;101.452;1.11725;239.123	5	5	5	751645;553656;445170;436667;404604	ENSDARG00000070735;ENSDARG00000005651;ENSDARG00000026183;ENSDARG00000017385;ENSDARG00000020345	51.05178	50.7841	6.946574747456443	26.03012	26.9678	2.6215445060116993	103.4856	92.7866	36.861273206985125	60.6068;41.759;50.7841;48.2892;53.8198	22.0961;24.7404;27.7952;26.9678;28.5511	166.237;70.4846;92.7866;86.4678;101.452	5	80963;767657;550506;403031;100005849	ENSDARG00000076799;ENSDARG00000071004;ENSDARG00000051920;ENSDARG00000019144;ENSDARG00000070434	57.3559852	72.0116	37.16410205042087	24.61279896	32.056	14.217013116100919	137.10468999999998	161.769	100.72068648696504	72.0116;84.515;40.6531;0.201926;89.3983	32.056;33.067;24.4822;0.0364948;33.4223	161.769;216.009;67.5052;1.11725;239.123	0						Hill,1(0.1);Linear,9(0.9)	Infinity	Infinity	1.9996205568313599	Infinity	NaN	3.631503105163574	38.446410301383054	69.96135489861693	19.329976648442454	31.312942311557542	74.6368906016526	165.95339939834741	CONFLICT	0.5	0.5	0.0	
R-DRE-1640170	Cell Cycle	328	392	25	16	12	17	17	15	25	7	7	22	385	4478	0.99849	0.006667	0.006667	1.79	550576;436667;406457;404604;404050;394141;337461	anapc16;b9d2;rcc1;clasp2;rnf8;dctn2;nup35	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000037158;ENSDARG00000020345;ENSDARG00000044949;ENSDARG00000031388;ENSDARG00000012222		59.28174285714285	63.3832	30.7771	17.039479316952633	53.472185788115155	15.829744609593273	28.88647142857143	30.8025	20.0664	4.3947656553807635	27.564742123749554	4.45634657970236	124.03308571428569	130.426	47.2048	53.106307755025036	105.61248909764996	46.69310437013984					69.6462;48.2892;63.3832;53.8198;64.7888;30.7771;84.2679	31.7026;26.9678;30.8025;28.5511;30.9207;20.0664;33.1942	153.003;86.4678;130.426;101.452;135.753;47.2048;213.925	2	5	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	5	550576;406457;404050;394141;337461	ENSDARG00000013822;ENSDARG00000037158;ENSDARG00000044949;ENSDARG00000031388;ENSDARG00000012222	62.57264	64.7888	19.603853537582843	29.33728	30.9207	5.269579563589507	136.06235999999998	135.753	59.74342268859396	69.6462;63.3832;64.7888;30.7771;84.2679	31.7026;30.8025;30.9207;20.0664;33.1942	153.003;130.426;135.753;47.2048;213.925	0						Linear,7(1)	3.2205048998066244	28.888179540634155	1.7563469409942627	13.281916618347168	4.072292075336431	2.8268096446990967	46.65871992919093	71.90476578509478	25.630783470098752	32.14215938704411	84.69138237106174	163.37478905750967	DOWN	0.2857142857142857	0.7142857142857143	0.0	
R-DRE-194138	Signaling by VEGF	47	62	2	2	1	2	2	2	2	1	1	28	61	4802	0.94846	0.30993	0.30993	1.61	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-198693	AKT phosphorylates targets in the nucleus	5	7	1	1	1	0	0	0	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-199418	Negative regulation of the PI3K/AKT network	40	69	4	2	0	3	3	3	4	0	0	29	69	4794	0.66157	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-199991	Membrane Trafficking	261	314	20	14	6	17	17	16	20	3	3	26	311	4552	0.88828	0.28434	0.42955	0.96	437015;403031;394141	trappc1;rab4a;dctn2	ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388		27.41310866666667	30.7771	0.201926	25.694877254990445	27.493793665040872	21.407339199833313	15.990731599999998	20.0664	0.0364948	14.357038901018404	16.75615577431748	12.258543235034306	47.53521666666666	47.2048	1.11725	46.584053864609444	45.600819337079884	38.27896978177643					51.2603;0.201926;30.7771	27.8693;0.0364948;20.0664	94.2836;1.11725;47.2048	0	3	0															3	437015;403031;394141	ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388	27.41310866666667	30.7771	25.694877254990445	15.990731599999998	20.0664	14.357038901018404	47.53521666666666	47.2048	46.584053864609444	51.2603;0.201926;30.7771	27.8693;0.0364948;20.0664	94.2836;1.11725;47.2048	0						Hill,1(0.34);Linear,2(0.67)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	NaN	-1.6633821612610618	56.489599494594394	-0.25578733756704963	32.23725053756705	-5.17960276913886	100.2500361024722	DOWN	0.0	1.0	0.0	
R-DRE-212436	Generic Transcription Pathway	386	488	24	14	9	14	14	12	24	2	2	27	486	4377	0.43612	0.80084	1.0	0.41	445170;393690	polr2eb;med30	ENSDARG00000026183;ENSDARG00000101115		50.27365	50.27365	49.7632	0.7218853129129792	50.5894009999841	0.567204563642647	27.587699999999998	27.587699999999998	27.3802	0.2934493141926329	27.716054065034182	0.2305709608316541	91.61535	91.61535	90.4441	1.656397634929087	92.33985457190983	1.3014758451716637					50.7841;49.7632	27.7952;27.3802	92.7866;90.4441	1	1	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	1	393690	ENSDARG00000101115	49.7632	49.7632		27.3802	27.3802		90.4441	90.4441		49.7632	27.3802	90.4441	0						Linear,2(1)	2.139406239530337	4.288584351539612	1.9996205568313599	2.288963794708252	0.2045965655932227	2.144292175769806	49.273168	51.27413200000001	27.180999999999994	27.994400000000002	89.31970000000001	93.911	CONFLICT	0.5	0.5	0.0	
R-DRE-3700989	Transcriptional Regulation by TP53	175	210	9	3	3	4	4	2	9	1	1	28	209	4654	0.64435	0.72089	1.0	0.48	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-372790	Signaling by GPCR	156	374	11	7	5	7	7	6	11	2	2	27	372	4491	0.61579	0.66209	1.0	0.53	767657;553656	abhd12;hrasb	ENSDARG00000071004;ENSDARG00000005651		63.137	63.137	41.759	30.23305753641203	55.16033960728128	28.04966213626227	28.9037	28.9037	24.7404	5.887795324227897	27.350269828187585	5.462585759748367	143.2468	143.2468	70.4846	102.90129006810358	116.09742406085331	95.46988148054736					84.515;41.759	33.067;24.7404	216.009;70.4846	1	1	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	1	767657	ENSDARG00000071004	84.515	84.515		33.067	33.067		216.009	216.009		84.515	33.067	216.009	0						Linear,2(1)	3.059474616706425	6.415349245071411	2.24393630027771	4.171412944793701	1.3629318059159499	3.2076746225357056	21.23612	105.03788	20.743632	37.063767999999996	0.6328880000000368	285.860712	CONFLICT	0.5	0.5	0.0	
R-DRE-388396	GPCR downstream signalling	148	360	11	7	5	7	7	6	11	2	2	27	358	4505	0.6391	0.64084	1.0	0.56	767657;553656	abhd12;hrasb	ENSDARG00000071004;ENSDARG00000005651		63.137	63.137	41.759	30.23305753641203	55.16033960728128	28.04966213626227	28.9037	28.9037	24.7404	5.887795324227897	27.350269828187585	5.462585759748367	143.2468	143.2468	70.4846	102.90129006810358	116.09742406085331	95.46988148054736					84.515;41.759	33.067;24.7404	216.009;70.4846	1	1	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	1	767657	ENSDARG00000071004	84.515	84.515		33.067	33.067		216.009	216.009		84.515	33.067	216.009	0						Linear,2(1)	3.059474616706425	6.415349245071411	2.24393630027771	4.171412944793701	1.3629318059159499	3.2076746225357056	21.23612	105.03788	20.743632	37.063767999999996	0.6328880000000368	285.860712	CONFLICT	0.5	0.5	0.0	
R-DRE-388841	Costimulation by the CD28 family	22	34	1	0	0	0	0	0	1	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-389513	CTLA4 inhibitory signaling	13	16	1	0	0	0	0	0	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4420097	VEGFA-VEGFR2 Pathway	46	58	2	2	1	2	2	2	2	1	1	28	57	4806	0.95429	0.29311	0.29311	1.72	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-453279	Mitotic G1 phase and G1/S transition	83	94	8	3	2	6	6	5	8	0	0	29	94	4769	0.56876	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5357801	Programmed Cell Death	61	77	3	2	0	3	3	3	3	0	0	29	77	4786	0.63039	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5633007	Regulation of TP53 Activity	86	107	4	1	1	1	1	0	4	0	0	29	107	4756	0.52561	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5653656	Vesicle-mediated transport	274	337	20	14	6	17	17	16	20	3	3	26	334	4529	0.86474	0.32252	0.44794	0.89	437015;403031;394141	trappc1;rab4a;dctn2	ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388		27.41310866666667	30.7771	0.201926	25.694877254990445	27.493793665040872	21.407339199833313	15.990731599999998	20.0664	0.0364948	14.357038901018404	16.75615577431748	12.258543235034306	47.53521666666666	47.2048	1.11725	46.584053864609444	45.600819337079884	38.27896978177643					51.2603;0.201926;30.7771	27.8693;0.0364948;20.0664	94.2836;1.11725;47.2048	0	3	0															3	437015;403031;394141	ENSDARG00000039005;ENSDARG00000019144;ENSDARG00000031388	27.41310866666667	30.7771	25.694877254990445	15.990731599999998	20.0664	14.357038901018404	47.53521666666666	47.2048	46.584053864609444	51.2603;0.201926;30.7771	27.8693;0.0364948;20.0664	94.2836;1.11725;47.2048	0						Hill,1(0.34);Linear,2(0.67)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	NaN	-1.6633821612610618	56.489599494594394	-0.25578733756704963	32.23725053756705	-5.17960276913886	100.2500361024722	DOWN	0.0	1.0	0.0	
R-DRE-6804757	Regulation of TP53 Degradation	20	25	1	0	0	0	0	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6804758	Regulation of TP53 Activity through Acetylation	17	24	1	1	1	0	0	0	1	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6806003	Regulation of TP53 Expression and Degradation	20	25	1	0	0	0	0	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6807070	PTEN Regulation	64	79	5	3	2	3	3	3	5	0	0	29	79	4784	0.62281	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69202	Cyclin E associated events during G1/S transition 	47	51	4	2	1	3	3	3	4	0	0	29	51	4812	0.73727	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69206	G1/S Transition	69	77	7	2	1	5	5	5	7	0	0	29	77	4786	0.63039	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69242	S Phase	92	101	7	4	3	5	5	5	7	1	1	28	100	4763	0.88033	0.45488	0.45488	0.99	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-69278	Cell Cycle, Mitotic	279	331	22	14	10	15	15	14	22	6	6	23	325	4538	0.99741	0.011531	0.011531	1.81	550576;436667;406457;404604;394141;337461	anapc16;b9d2;rcc1;clasp2;dctn2;nup35	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000037158;ENSDARG00000020345;ENSDARG00000031388;ENSDARG00000012222		58.363899999999994	58.6015	30.7771	18.475285334305426	51.91369324390889	16.405993640854607	28.54743333333333	29.6768	20.0664	4.712876491768803	27.102568965693695	4.595860168263871	122.07976666666666	115.939	47.2048	57.898929899529804	101.4616220060999	48.79106655475698					69.6462;48.2892;63.3832;53.8198;30.7771;84.2679	31.7026;26.9678;30.8025;28.5511;20.0664;33.1942	153.003;86.4678;130.426;101.452;47.2048;213.925	2	4	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	4	550576;406457;394141;337461	ENSDARG00000013822;ENSDARG00000037158;ENSDARG00000031388;ENSDARG00000012222	62.0186	66.5147	22.591333793145832	28.941425000000002	31.25255	5.9983289752924716	136.1397	141.7145	68.98547332272207	69.6462;63.3832;30.7771;84.2679	31.7026;30.8025;20.0664;33.1942	153.003;130.426;47.2048;213.925	0						Linear,6(1)	3.29125751856613	26.06136989593506	1.7563469409942627	13.281916618347168	4.4165481527883514	2.71774959564209	43.58059283901797	73.14720716098202	24.776346742306757	32.31851992435991	75.7509739303733	168.40855940296004	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-69656	Cyclin A:Cdk2-associated events at S phase entry	48	52	4	2	1	3	3	3	4	0	0	29	52	4811	0.73286	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73857	RNA Polymerase II Transcription	416	524	25	14	9	15	15	13	25	2	2	27	522	4341	0.38555	0.83324	0.76327	0.38	445170;393690	polr2eb;med30	ENSDARG00000026183;ENSDARG00000101115		50.27365	50.27365	49.7632	0.7218853129129792	50.5894009999841	0.567204563642647	27.587699999999998	27.587699999999998	27.3802	0.2934493141926329	27.716054065034182	0.2305709608316541	91.61535	91.61535	90.4441	1.656397634929087	92.33985457190983	1.3014758451716637					50.7841;49.7632	27.7952;27.3802	92.7866;90.4441	1	1	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	1	393690	ENSDARG00000101115	49.7632	49.7632		27.3802	27.3802		90.4441	90.4441		49.7632	27.3802	90.4441	0						Linear,2(1)	2.139406239530337	4.288584351539612	1.9996205568313599	2.288963794708252	0.2045965655932227	2.144292175769806	49.273168	51.27413200000001	27.180999999999994	27.994400000000002	89.31970000000001	93.911	CONFLICT	0.5	0.5	0.0	
R-DRE-74160	Gene expression (Transcription)	472	586	29	16	11	17	17	14	29	3	3	26	583	4280	0.53556	0.69264	1.0	0.51	445170;393690;337461	polr2eb;med30;nup35	ENSDARG00000026183;ENSDARG00000101115;ENSDARG00000012222		61.605066666666666	50.7841	49.7632	19.633226179701914	56.68066476703299	15.882674186223822	29.45653333333333	27.7952	27.3802	3.243558282709524	28.70685926226841	2.5887799289371483	132.38523333333333	92.7866	90.4441	70.62522203578078	114.33035928404516	57.32578160140491					50.7841;49.7632;84.2679	27.7952;27.3802;33.1942	92.7866;90.4441;213.925	1	2	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	2	393690;337461	ENSDARG00000101115;ENSDARG00000012222	67.01554999999999	67.01554999999999	24.398507352807506	30.2872	30.2872	4.111118825818615	152.18455	152.18455	87.314181737018	49.7632;84.2679	27.3802;33.1942	90.4441;213.925	0						Linear,3(1)	3.9320203353002467	17.57050096988678	1.9996205568313599	13.281916618347168	6.431937703260594	2.288963794708252	39.387979763639706	83.82215356969363	25.786101607930384	33.12696505873628	52.465271063620506	212.30519560304617	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-8876198	RAB GEFs exchange GTP for GDP on RABs	38	46	2	2	2	1	1	1	2	1	1	28	45	4818	0.9701	0.24025	0.24025	2.17	437015	trappc1	ENSDARG00000039005		51.2603	51.2603	51.2603		51.2603		27.8693	27.8693	27.8693		27.8693		94.2836	94.2836	94.2836		94.2836						51.2603	27.8693	94.2836	0	1	0															1	437015	ENSDARG00000039005	51.2603	51.2603		27.8693	27.8693		94.2836	94.2836		51.2603	27.8693	94.2836	0						Linear,1(1)	1.5924749374389648	1.5924749374389648	1.5924749374389648	1.5924749374389648	0.0	1.5924749374389648	51.2603	51.2603	27.8693	27.8693	94.2836	94.2836	DOWN	0.0	1.0	0.0	
R-DRE-8878166	Transcriptional regulation by RUNX2	43	48	4	2	1	3	3	3	4	0	0	29	48	4815	0.75068	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8939211	ESR-mediated signaling	89	118	9	7	5	5	5	5	9	2	2	27	116	4747	0.96831	0.15399	0.15399	1.69	553656;445170	hrasb;polr2eb	ENSDARG00000005651;ENSDARG00000026183		46.271550000000005	46.271550000000005	41.759	6.3817094108866455	47.31308732071834	6.209397315690282	26.2678	26.2678	24.7404	2.160069795168673	26.620337723385934	2.1017458997651888	81.63560000000001	81.63560000000001	70.4846	15.769895434022395	84.20935157357374	15.344093576195828					41.759;50.7841	24.7404;27.7952	70.4846;92.7866	2	0	2	553656;445170	ENSDARG00000005651;ENSDARG00000026183	46.271550000000005	46.271550000000005	6.3817094108866455	26.2678	26.2678	2.160069795168673	81.63560000000001	81.63560000000001	15.769895434022395	41.759;50.7841	24.7404;27.7952	70.4846;92.7866	0															0						Linear,2(1)	2.8881210285308203	6.171033501625061	1.9996205568313599	4.171412944793701	1.5356891248574969	3.0855167508125305	37.426952	55.11614800000001	23.274096	29.261504000000002	59.77964	103.49156000000002	UP	1.0	0.0	0.0	
R-DRE-8948751	Regulation of PTEN stability and activity	40	46	4	2	1	3	3	3	4	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9006925	Intracellular signaling by second messengers	125	175	11	6	3	7	7	7	11	0	0	29	175	4688	0.34663	1.0	0.62484	0.0																														0	0	0															0															0																							
R-DRE-9006931	Signaling by Nuclear Receptors	123	155	11	8	5	6	6	6	11	2	2	27	153	4710	0.93751	0.23378	0.23378	1.29	553656;445170	hrasb;polr2eb	ENSDARG00000005651;ENSDARG00000026183		46.271550000000005	46.271550000000005	41.759	6.3817094108866455	47.31308732071834	6.209397315690282	26.2678	26.2678	24.7404	2.160069795168673	26.620337723385934	2.1017458997651888	81.63560000000001	81.63560000000001	70.4846	15.769895434022395	84.20935157357374	15.344093576195828					41.759;50.7841	24.7404;27.7952	70.4846;92.7866	2	0	2	553656;445170	ENSDARG00000005651;ENSDARG00000026183	46.271550000000005	46.271550000000005	6.3817094108866455	26.2678	26.2678	2.160069795168673	81.63560000000001	81.63560000000001	15.769895434022395	41.759;50.7841	24.7404;27.7952	70.4846;92.7866	0															0						Linear,2(1)	2.8881210285308203	6.171033501625061	1.9996205568313599	4.171412944793701	1.5356891248574969	3.0855167508125305	37.426952	55.11614800000001	23.274096	29.261504000000002	59.77964	103.49156000000002	UP	1.0	0.0	0.0	
R-DRE-9006934	Signaling by Receptor Tyrosine Kinases	200	254	15	10	5	11	11	11	15	3	3	26	251	4612	0.93927	0.18874	0.18874	1.18	553656;445170;403031	hrasb;polr2eb;rab4a	ENSDARG00000005651;ENSDARG00000026183;ENSDARG00000019144		30.915008666666665	41.759	0.201926	26.97838380388317	38.38693461282997	23.123717182363638	17.5240316	24.7404	0.0364948	15.221478517493487	21.58349645595775	12.863845771491674	54.796150000000004	70.4846	1.11725	47.80599366091559	68.46588937327107	41.636225275835095					41.759;50.7841;0.201926	24.7404;27.7952;0.0364948	70.4846;92.7866;1.11725	2	1	2	553656;445170	ENSDARG00000005651;ENSDARG00000026183	46.271550000000005	46.271550000000005	6.3817094108866455	26.2678	26.2678	2.160069795168673	81.63560000000001	81.63560000000001	15.769895434022395	41.759;50.7841	24.7404;27.7952	70.4846;92.7866	1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(0.34);Linear,2(0.67)	Infinity	Infinity	1.9996205568313599	Infinity	NaN	NaN	0.3860934497796187	61.44392388355372	0.29930714970361905	34.74875605029638	0.6985755143459897	108.89372448565403	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-9007101	Rab regulation of trafficking	54	67	3	3	3	2	2	2	3	2	2	27	65	4798	0.99304	0.059188	0.059188	2.99	437015;403031	trappc1;rab4a	ENSDARG00000039005;ENSDARG00000019144		25.731113	25.731113	0.201926	36.10372249175891	23.51529730157856	35.96747279616954	13.9528974	13.9528974	0.0364948	19.680765296364203	12.745017832717542	19.606493224247334	47.700425	47.700425	1.11725	65.8785578633993	43.65722023804212	65.62994268370964					51.2603;0.201926	27.8693;0.0364948	94.2836;1.11725	0	2	0															2	437015;403031	ENSDARG00000039005;ENSDARG00000019144	25.731113	25.731113	36.10372249175891	13.9528974	13.9528974	19.680765296364203	47.700425	47.700425	65.8785578633993	51.2603;0.201926	27.8693;0.0364948	94.2836;1.11725	0						Hill,1(0.5);Linear,1(0.5)	Infinity	Infinity	1.5924749374389648	Infinity	NaN	Infinity	-24.306093519999997	75.76831952	-13.323251695999994	41.229046495999995	-43.60259799999999	139.003448	DOWN	0.0	1.0	0.0	
R-DRE-9009391	Extra-nuclear estrogen signaling	35	44	3	3	2	2	2	2	3	1	1	28	43	4820	0.97247	0.23108	0.23108	2.27	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-9607240	FLT3 Signaling	5	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9614085	FOXO-mediated transcription	16	19	2	1	1	1	1	1	2	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9614399	Regulation of localization of FOXO transcription factors	9	11	1	1	1	0	0	0	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9634638	Estrogen-dependent nuclear events downstream of ESR-membrane signaling	4	5	1	1	1	0	0	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211945	Phase I - Functionalization of compounds	52	61	5	5	2	5	5	4	5	1	1	28	60	4803	0.94994	0.30576	0.30576	1.64	436914	acss2	ENSDARG00000037781		37.9274	37.9274	37.9274		37.9274		23.3493	23.3493	23.3493		23.3493		61.6071	61.6071	61.6071		61.6071						37.9274	23.3493	61.6071	1	0	1	436914	ENSDARG00000037781	37.9274	37.9274		23.3493	23.3493		61.6071	61.6071		37.9274	23.3493	61.6071	0															0						Linear,1(1)	1.7204608917236328	1.7204608917236328	1.7204608917236328	1.7204608917236328	0.0	1.7204608917236328	37.9274	37.9274	23.3493	23.3493	61.6071	61.6071	UP	1.0	0.0	0.0	
R-DRE-373076	Class A/1 (Rhodopsin-like receptors)	52	219	2	1	0	2	2	2	2	0	0	29	219	4644	0.26392	1.0	0.63915	0.0																														0	0	0															0															0																							
R-DRE-375276	Peptide ligand-binding receptors	35	108	2	1	0	2	2	2	2	0	0	29	108	4755	0.52242	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-380108	Chemokine receptors bind chemokines	6	25	1	0	0	1	1	1	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416476	G alpha (q) signalling events	55	125	5	4	3	5	5	4	5	2	2	27	123	4740	0.96331	0.16866	0.16866	1.6	767657;553656	abhd12;hrasb	ENSDARG00000071004;ENSDARG00000005651		63.137	63.137	41.759	30.23305753641203	55.16033960728128	28.04966213626227	28.9037	28.9037	24.7404	5.887795324227897	27.350269828187585	5.462585759748367	143.2468	143.2468	70.4846	102.90129006810358	116.09742406085331	95.46988148054736					84.515;41.759	33.067;24.7404	216.009;70.4846	1	1	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	1	767657	ENSDARG00000071004	84.515	84.515		33.067	33.067		216.009	216.009		84.515	33.067	216.009	0						Linear,2(1)	3.059474616706425	6.415349245071411	2.24393630027771	4.171412944793701	1.3629318059159499	3.2076746225357056	21.23612	105.03788	20.743632	37.063767999999996	0.6328880000000368	285.860712	CONFLICT	0.5	0.5	0.0	
R-DRE-418594	G alpha (i) signalling events	81	166	4	1	1	1	1	1	4	0	0	29	166	4697	0.36639	1.0	0.62457	0.0																														0	0	0															0															0																							
R-DRE-500792	GPCR ligand binding	79	264	3	2	1	3	3	2	3	0	0	29	264	4599	0.19918	1.0	0.40322	0.0																														0	0	0															0															0																							
R-DRE-983168	Antigen processing: Ubiquitination & Proteasome degradation	154	193	15	10	4	13	13	8	15	1	1	28	192	4671	0.68177	0.68986	1.0	0.52	378451	fbxl3a	ENSDARG00000103505		41.3714	41.3714	41.3714		41.3714		24.6021	24.6021	24.6021		24.6021		69.571	69.571	69.571		69.571						41.3714	24.6021	69.571	1	0	1	378451	ENSDARG00000103505	41.3714	41.3714		24.6021	24.6021		69.571	69.571		41.3714	24.6021	69.571	0															0						Linear,1(1)	3.3780648708343506	3.3780648708343506	3.3780648708343506	3.3780648708343506	0.0	3.3780648708343506	41.3714	41.3714	24.6021	24.6021	69.571	69.571	UP	1.0	0.0	0.0	
R-DRE-983169	Class I MHC mediated antigen processing & presentation	175	231	15	10	4	13	13	8	15	1	1	28	230	4633	0.59902	0.7551	1.0	0.43	378451	fbxl3a	ENSDARG00000103505		41.3714	41.3714	41.3714		41.3714		24.6021	24.6021	24.6021		24.6021		69.571	69.571	69.571		69.571						41.3714	24.6021	69.571	1	0	1	378451	ENSDARG00000103505	41.3714	41.3714		24.6021	24.6021		69.571	69.571		41.3714	24.6021	69.571	0															0						Linear,1(1)	3.3780648708343506	3.3780648708343506	3.3780648708343506	3.3780648708343506	0.0	3.3780648708343506	41.3714	41.3714	24.6021	24.6021	69.571	69.571	UP	1.0	0.0	0.0	
R-DRE-397014	Muscle contraction	64	92	1	1	0	1	1	1	1	0	0	29	92	4771	0.5757	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5576891	Cardiac conduction	35	61	1	1	0	1	1	1	1	0	0	29	61	4802	0.69424	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1236975	Antigen processing-Cross presentation	46	65	4	2	1	3	3	3	4	0	0	29	65	4798	0.67772	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-382551	Transport of small molecules	267	372	14	9	4	9	9	7	14	0	0	29	372	4491	0.10021	1.0	0.16493	0.0																														0	0	0															0															0																							
R-DRE-917937	Iron uptake and transport	33	45	2	2	0	2	2	2	2	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-109704	PI3K Cascade	15	31	1	1	0	1	1	1	1	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112399	IRS-mediated signalling	15	31	1	1	0	1	1	1	1	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-190236	Signaling by FGFR	47	64	7	4	3	4	4	4	7	2	2	27	62	4801	0.99388	0.054556	0.054556	3.12	553656;445170	hrasb;polr2eb	ENSDARG00000005651;ENSDARG00000026183		46.271550000000005	46.271550000000005	41.759	6.3817094108866455	47.31308732071834	6.209397315690282	26.2678	26.2678	24.7404	2.160069795168673	26.620337723385934	2.1017458997651888	81.63560000000001	81.63560000000001	70.4846	15.769895434022395	84.20935157357374	15.344093576195828					41.759;50.7841	24.7404;27.7952	70.4846;92.7866	2	0	2	553656;445170	ENSDARG00000005651;ENSDARG00000026183	46.271550000000005	46.271550000000005	6.3817094108866455	26.2678	26.2678	2.160069795168673	81.63560000000001	81.63560000000001	15.769895434022395	41.759;50.7841	24.7404;27.7952	70.4846;92.7866	0															0						Linear,2(1)	2.8881210285308203	6.171033501625061	1.9996205568313599	4.171412944793701	1.5356891248574969	3.0855167508125305	37.426952	55.11614800000001	23.274096	29.261504000000002	59.77964	103.49156000000002	UP	1.0	0.0	0.0	
R-DRE-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	18	36	2	2	0	2	2	2	2	0	0	29	36	4827	0.80669	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2428924	IGF1R signaling cascade	17	35	2	2	0	2	2	2	2	0	0	29	35	4828	0.81153	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2428928	IRS-related events triggered by IGF1R	16	34	2	2	0	2	2	2	2	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654712	FRS-mediated FGFR4 signaling	6	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654716	Downstream signaling of activated FGFR4	9	19	2	2	1	2	2	2	2	1	1	28	18	4845	0.99455	0.10701	0.10701	5.26	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654719	SHC-mediated cascade:FGFR4	7	14	1	1	1	1	1	1	1	1	1	28	13	4850	0.99705	0.079972	0.079972	7.14	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654720	PI-3K cascade:FGFR4	6	15	1	1	0	1	1	1	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654733	Negative regulation of FGFR4 signaling	16	24	1	0	0	0	0	0	1	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654743	Signaling by FGFR4	21	31	3	2	1	2	2	2	3	1	1	28	30	4833	0.98581	0.1688	0.1688	3.23	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5673001	RAF/MAP kinase cascade	119	157	10	5	2	7	7	7	10	1	1	28	156	4707	0.7618	0.61277	0.61277	0.64	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5683057	MAPK family signaling cascades	139	180	11	6	3	7	7	7	11	1	1	28	179	4684	0.71065	0.6639	1.0	0.56	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5684996	MAPK1/MAPK3 signaling	122	161	10	5	2	7	7	7	10	1	1	28	160	4703	0.75293	0.62217	0.62217	0.62	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	39	67	4	2	0	3	3	3	4	0	0	29	67	4796	0.6696	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-74751	Insulin receptor signalling cascade	18	34	1	1	0	1	1	1	1	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-74752	Signaling by Insulin receptor	30	46	1	1	0	1	1	1	1	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-141424	Amplification of signal from the kinetochores	53	61	4	3	2	3	3	3	4	2	2	27	59	4804	0.99465	0.050062	0.050062	3.28	436667;404604	b9d2;clasp2	ENSDARG00000017385;ENSDARG00000020345		51.054500000000004	51.054500000000004	48.2892	3.910724764030367	50.64868568205786	3.8683843731855836	27.75945	27.75945	26.9678	1.1195621666526443	27.643273489386726	1.1074409608478568	93.9599	93.9599	86.4678	10.59542943065536	92.86041659803483	10.480715496453646					48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	0	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	0															0						Linear,2(1)	2.6426975638485004	5.350574254989624	2.2589809894561768	3.0915932655334473	0.5887457865134038	2.675287127494812	45.63451200000001	56.474488	26.207816	29.311084	79.275384	108.644416	UP	1.0	0.0	0.0	
R-DRE-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	53	61	4	3	2	3	3	3	4	2	2	27	59	4804	0.99465	0.050062	0.050062	3.28	436667;404604	b9d2;clasp2	ENSDARG00000017385;ENSDARG00000020345		51.054500000000004	51.054500000000004	48.2892	3.910724764030367	50.64868568205786	3.8683843731855836	27.75945	27.75945	26.9678	1.1195621666526443	27.643273489386726	1.1074409608478568	93.9599	93.9599	86.4678	10.59542943065536	92.86041659803483	10.480715496453646					48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	0	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	0															0						Linear,2(1)	2.6426975638485004	5.350574254989624	2.2589809894561768	3.0915932655334473	0.5887457865134038	2.675287127494812	45.63451200000001	56.474488	26.207816	29.311084	79.275384	108.644416	UP	1.0	0.0	0.0	
R-DRE-194315	Signaling by Rho GTPases	313	394	16	13	9	13	13	10	16	5	5	24	389	4474	0.97457	0.078872	0.078872	1.27	80963;751645;436667;404604;100005849	rnd3a;rnd2;b9d2;clasp2;rhov	ENSDARG00000076799;ENSDARG00000070735;ENSDARG00000017385;ENSDARG00000020345;ENSDARG00000070434		64.82514	60.6068	48.2892	16.3388693938106	59.92336655650439	13.941652578988016	28.61866	28.5511	22.0961	4.476716306959819	28.025054815440797	3.919473820948471	151.00976	161.769	86.4678	60.6902161051351	131.9092449086714	53.02556540163244					72.0116;60.6068;48.2892;53.8198;89.3983	32.056;22.0961;26.9678;28.5511;33.4223	161.769;166.237;86.4678;101.452;239.123	3	2	3	751645;436667;404604	ENSDARG00000070735;ENSDARG00000017385;ENSDARG00000020345	54.2386	53.8198	6.169470197674969	25.87166666666667	26.9678	3.364206810428446	118.05226666666665	101.452	42.39643802506684	60.6068;48.2892;53.8198	22.0961;26.9678;28.5511	166.237;86.4678;101.452	2	80963;100005849	ENSDARG00000076799;ENSDARG00000070434	80.70495	80.70495	12.294253472456262	32.739149999999995	32.739149999999995	0.9661199951355175	200.446	200.446	54.69753795190404	72.0116;89.3983	32.056;33.4223	161.769;239.123	0						Linear,5(1)	3.391594702332888	18.575299978256226	2.063920497894287	5.664744853973389	1.7470240311800889	3.0915932655334473	50.50348952509992	79.14679047490009	24.694645144489158	32.54267485551084	97.81244007814804	204.20707992185197	UP	0.6	0.4	0.0	
R-DRE-195258	RHO GTPase Effectors	145	179	8	6	4	6	6	4	8	2	2	27	177	4686	0.91214	0.28712	0.28712	1.12	436667;404604	b9d2;clasp2	ENSDARG00000017385;ENSDARG00000020345		51.054500000000004	51.054500000000004	48.2892	3.910724764030367	50.64868568205786	3.8683843731855836	27.75945	27.75945	26.9678	1.1195621666526443	27.643273489386726	1.1074409608478568	93.9599	93.9599	86.4678	10.59542943065536	92.86041659803483	10.480715496453646					48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	0	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	0															0						Linear,2(1)	2.6426975638485004	5.350574254989624	2.2589809894561768	3.0915932655334473	0.5887457865134038	2.675287127494812	45.63451200000001	56.474488	26.207816	29.311084	79.275384	108.644416	UP	1.0	0.0	0.0	
R-DRE-2467813	Separation of Sister Chromatids	113	129	10	7	5	7	7	7	10	3	3	26	126	4737	0.99343	0.039732	0.039732	2.33	550576;436667;404604	anapc16;b9d2;clasp2	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000020345		57.251733333333334	53.8198	48.2892	11.08440287310658	54.05792398524311	9.430027545198657	29.073833333333337	28.5511	26.9678	2.410294663175677	28.371748341070226	2.096285660103565	113.64093333333334	101.452	86.4678	34.90216012818303	103.65342854448949	29.437143532073172					69.6462;48.2892;53.8198	31.7026;26.9678;28.5511	153.003;86.4678;101.452	2	1	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,3(1)	2.3062253722985155	7.106921195983887	1.7563469409942627	3.0915932655334473	0.6743845263328615	2.2589809894561768	44.70855068744842	69.79491597921823	26.34632815901613	31.801338507650534	74.14542110453371	153.13644556213296	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-2500257	Resolution of Sister Chromatid Cohesion	67	78	5	4	3	3	3	3	5	2	2	27	76	4787	0.98942	0.077266	0.077266	2.56	436667;404604	b9d2;clasp2	ENSDARG00000017385;ENSDARG00000020345		51.054500000000004	51.054500000000004	48.2892	3.910724764030367	50.64868568205786	3.8683843731855836	27.75945	27.75945	26.9678	1.1195621666526443	27.643273489386726	1.1074409608478568	93.9599	93.9599	86.4678	10.59542943065536	92.86041659803483	10.480715496453646					48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	0	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	0															0						Linear,2(1)	2.6426975638485004	5.350574254989624	2.2589809894561768	3.0915932655334473	0.5887457865134038	2.675287127494812	45.63451200000001	56.474488	26.207816	29.311084	79.275384	108.644416	UP	1.0	0.0	0.0	
R-DRE-2555396	Mitotic Metaphase and Anaphase	140	156	13	9	7	10	10	10	13	5	5	24	151	4712	0.99975	0.0019755	0.0019755	3.21	550576;436667;406457;404604;337461	anapc16;b9d2;rcc1;clasp2;nup35	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000037158;ENSDARG00000020345;ENSDARG00000012222		63.88126	63.3832	48.2892	14.084060137545574	57.89531490564413	12.528069941076586	30.24364	30.8025	26.9678	2.4870923008606094	29.093793389381343	2.3998097643536926	137.05476	130.426	86.4678	50.08472236508864	116.81621477625353	42.95878842889097					69.6462;48.2892;63.3832;53.8198;84.2679	31.7026;26.9678;30.8025;28.5511;33.1942	153.003;86.4678;130.426;101.452;213.925	2	3	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	3	550576;406457;337461	ENSDARG00000013822;ENSDARG00000037158;ENSDARG00000012222	72.43243333333334	69.6462	10.717508836634178	31.899766666666665	31.7026	1.2079789912633327	165.78466666666665	153.003	43.19200160137685	69.6462;63.3832;84.2679	31.7026;30.8025;33.1942	153.003;130.426;213.925	0						Linear,5(1)	3.522461067164151	23.717463970184326	1.7563469409942627	13.281916618347168	4.814850473122581	3.0915932655334473	51.53603698023521	76.22648301976479	28.063607479192072	32.423672520807926	93.15356521372352	180.95595478627644	DOWN	0.4	0.6	0.0	
R-DRE-5663220	RHO GTPases Activate Formins	70	79	5	4	2	4	4	4	5	2	2	27	77	4786	0.98905	0.078989	0.078989	2.53	436667;404604	b9d2;clasp2	ENSDARG00000017385;ENSDARG00000020345		51.054500000000004	51.054500000000004	48.2892	3.910724764030367	50.64868568205786	3.8683843731855836	27.75945	27.75945	26.9678	1.1195621666526443	27.643273489386726	1.1074409608478568	93.9599	93.9599	86.4678	10.59542943065536	92.86041659803483	10.480715496453646					48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	0	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	0															0						Linear,2(1)	2.6426975638485004	5.350574254989624	2.2589809894561768	3.0915932655334473	0.5887457865134038	2.675287127494812	45.63451200000001	56.474488	26.207816	29.311084	79.275384	108.644416	UP	1.0	0.0	0.0	
R-DRE-68877	Mitotic Prometaphase	100	119	8	6	4	5	5	5	8	3	3	26	116	4747	0.99506	0.032377	0.032377	2.52	436667;404604;394141	b9d2;clasp2;dctn2	ENSDARG00000017385;ENSDARG00000020345;ENSDARG00000031388		44.295366666666666	48.2892	30.7771	12.029319778912429	44.623783727712244	11.530735187173454	25.1951	26.9678	20.0664	4.51158314674571	25.346027531040626	4.339797461229901	78.37486666666666	86.4678	47.2048	28.014484725108435	79.0180077400081	26.79483201315341					48.2892;53.8198;30.7771	26.9678;28.5511;20.0664	86.4678;101.452;47.2048	2	1	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,3(1)	2.5390915991200225	7.6944801807403564	2.2589809894561768	3.0915932655334473	0.4581651458354582	2.3439059257507324	30.68290988212125	57.90782345121208	20.08976306127976	30.30043693872024	46.67349288405664	110.07624044927668	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-68882	Mitotic Anaphase	139	155	13	9	7	10	10	10	13	5	5	24	150	4713	0.99976	0.0019201	0.0019201	3.23	550576;436667;406457;404604;337461	anapc16;b9d2;rcc1;clasp2;nup35	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000037158;ENSDARG00000020345;ENSDARG00000012222		63.88126	63.3832	48.2892	14.084060137545574	57.89531490564413	12.528069941076586	30.24364	30.8025	26.9678	2.4870923008606094	29.093793389381343	2.3998097643536926	137.05476	130.426	86.4678	50.08472236508864	116.81621477625353	42.95878842889097					69.6462;48.2892;63.3832;53.8198;84.2679	31.7026;26.9678;30.8025;28.5511;33.1942	153.003;86.4678;130.426;101.452;213.925	2	3	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	3	550576;406457;337461	ENSDARG00000013822;ENSDARG00000037158;ENSDARG00000012222	72.43243333333334	69.6462	10.717508836634178	31.899766666666665	31.7026	1.2079789912633327	165.78466666666665	153.003	43.19200160137685	69.6462;63.3832;84.2679	31.7026;30.8025;33.1942	153.003;130.426;213.925	0						Linear,5(1)	3.522461067164151	23.717463970184326	1.7563469409942627	13.281916618347168	4.814850473122581	3.0915932655334473	51.53603698023521	76.22648301976479	28.063607479192072	32.423672520807926	93.15356521372352	180.95595478627644	DOWN	0.4	0.6	0.0	
R-DRE-68886	M Phase	211	252	19	13	9	12	12	12	19	6	6	23	246	4617	0.99948	0.0030685	0.0030685	2.38	550576;436667;406457;404604;394141;337461	anapc16;b9d2;rcc1;clasp2;dctn2;nup35	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000037158;ENSDARG00000020345;ENSDARG00000031388;ENSDARG00000012222		58.363899999999994	58.6015	30.7771	18.475285334305426	51.91369324390889	16.405993640854607	28.54743333333333	29.6768	20.0664	4.712876491768803	27.102568965693695	4.595860168263871	122.07976666666666	115.939	47.2048	57.898929899529804	101.4616220060999	48.79106655475698					69.6462;48.2892;63.3832;53.8198;30.7771;84.2679	31.7026;26.9678;30.8025;28.5511;20.0664;33.1942	153.003;86.4678;130.426;101.452;47.2048;213.925	2	4	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	4	550576;406457;394141;337461	ENSDARG00000013822;ENSDARG00000037158;ENSDARG00000031388;ENSDARG00000012222	62.0186	66.5147	22.591333793145832	28.941425000000002	31.25255	5.9983289752924716	136.1397	141.7145	68.98547332272207	69.6462;63.3832;30.7771;84.2679	31.7026;30.8025;20.0664;33.1942	153.003;130.426;47.2048;213.925	0						Linear,6(1)	3.29125751856613	26.06136989593506	1.7563469409942627	13.281916618347168	4.4165481527883514	2.71774959564209	43.58059283901797	73.14720716098202	24.776346742306757	32.31851992435991	75.7509739303733	168.40855940296004	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-69618	Mitotic Spindle Checkpoint	66	75	5	4	3	4	4	4	5	3	3	26	72	4791	0.99909	0.0095001	0.0095001	4.0	550576;436667;404604	anapc16;b9d2;clasp2	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000020345		57.251733333333334	53.8198	48.2892	11.08440287310658	54.05792398524311	9.430027545198657	29.073833333333337	28.5511	26.9678	2.410294663175677	28.371748341070226	2.096285660103565	113.64093333333334	101.452	86.4678	34.90216012818303	103.65342854448949	29.437143532073172					69.6462;48.2892;53.8198	31.7026;26.9678;28.5511	153.003;86.4678;101.452	2	1	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,3(1)	2.3062253722985155	7.106921195983887	1.7563469409942627	3.0915932655334473	0.6743845263328615	2.2589809894561768	44.70855068744842	69.79491597921823	26.34632815901613	31.801338507650534	74.14542110453371	153.13644556213296	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-69620	Cell Cycle Checkpoints	158	187	11	7	5	9	9	8	11	4	4	25	183	4680	0.99565	0.023241	0.023241	2.14	550576;436667;404604;404050	anapc16;b9d2;clasp2;rnf8	ENSDARG00000013822;ENSDARG00000017385;ENSDARG00000020345;ENSDARG00000044949		59.136	59.3043	48.2892	9.80363035750869	56.0139535663561	9.35529973341436	29.53555	29.7359	26.9678	2.173877341679299	28.8363725561704	2.117869183781968	119.16895	118.60249999999999	86.4678	30.56702571088656	109.50455488512415	28.89006794315424					69.6462;48.2892;53.8198;64.7888	31.7026;26.9678;28.5511;30.9207	153.003;86.4678;101.452;135.753	2	2	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	550576;404050	ENSDARG00000013822;ENSDARG00000044949	67.2175	67.2175	3.434700478935042	31.31165	31.31165	0.552886792209711	144.378	144.378	12.197591975467946	69.6462;64.7888	31.7026;30.9207	153.003;135.753	0						Linear,4(1)	2.426612611909929	9.933730840682983	1.7563469409942627	3.0915932655334473	0.5963218568680971	2.5428953170776367	49.52844224964145	68.74355775035855	27.405150205154285	31.665949794845716	89.21326480333117	149.1246351966688	CONFLICT	0.5	0.5	0.0	
R-DRE-9648025	EML4 and NUDC in mitotic spindle formation	59	69	4	3	2	3	3	3	4	2	2	27	67	4796	0.99245	0.06235	0.06235	2.9	436667;404604	b9d2;clasp2	ENSDARG00000017385;ENSDARG00000020345		51.054500000000004	51.054500000000004	48.2892	3.910724764030367	50.64868568205786	3.8683843731855836	27.75945	27.75945	26.9678	1.1195621666526443	27.643273489386726	1.1074409608478568	93.9599	93.9599	86.4678	10.59542943065536	92.86041659803483	10.480715496453646					48.2892;53.8198	26.9678;28.5511	86.4678;101.452	2	0	2	436667;404604	ENSDARG00000017385;ENSDARG00000020345	51.054500000000004	51.054500000000004	3.910724764030367	27.75945	27.75945	1.1195621666526443	93.9599	93.9599	10.59542943065536	48.2892;53.8198	26.9678;28.5511	86.4678;101.452	0															0						Linear,2(1)	2.6426975638485004	5.350574254989624	2.2589809894561768	3.0915932655334473	0.5887457865134038	2.675287127494812	45.63451200000001	56.474488	26.207816	29.311084	79.275384	108.644416	UP	1.0	0.0	0.0	
R-DRE-9716542	Signaling by Rho GTPases, Miro GTPases and RHOBTB3	319	403	16	13	9	13	13	10	16	5	5	24	398	4465	0.97192	0.085124	0.085124	1.24	80963;751645;436667;404604;100005849	rnd3a;rnd2;b9d2;clasp2;rhov	ENSDARG00000076799;ENSDARG00000070735;ENSDARG00000017385;ENSDARG00000020345;ENSDARG00000070434		64.82514	60.6068	48.2892	16.3388693938106	59.92336655650439	13.941652578988016	28.61866	28.5511	22.0961	4.476716306959819	28.025054815440797	3.919473820948471	151.00976	161.769	86.4678	60.6902161051351	131.9092449086714	53.02556540163244					72.0116;60.6068;48.2892;53.8198;89.3983	32.056;22.0961;26.9678;28.5511;33.4223	161.769;166.237;86.4678;101.452;239.123	3	2	3	751645;436667;404604	ENSDARG00000070735;ENSDARG00000017385;ENSDARG00000020345	54.2386	53.8198	6.169470197674969	25.87166666666667	26.9678	3.364206810428446	118.05226666666665	101.452	42.39643802506684	60.6068;48.2892;53.8198	22.0961;26.9678;28.5511	166.237;86.4678;101.452	2	80963;100005849	ENSDARG00000076799;ENSDARG00000070434	80.70495	80.70495	12.294253472456262	32.739149999999995	32.739149999999995	0.9661199951355175	200.446	200.446	54.69753795190404	72.0116;89.3983	32.056;33.4223	161.769;239.123	0						Linear,5(1)	3.391594702332888	18.575299978256226	2.063920497894287	5.664744853973389	1.7470240311800889	3.0915932655334473	50.50348952509992	79.14679047490009	24.694645144489158	32.54267485551084	97.81244007814804	204.20707992185197	UP	0.6	0.4	0.0	
R-DRE-1632852	Macroautophagy	73	85	2	0	0	2	2	1	2	0	0	29	85	4778	0.60062	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9612973	Autophagy	73	85	2	0	0	2	2	1	2	0	0	29	85	4778	0.60062	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1799339	SRP-dependent cotranslational protein targeting to membrane	63	64	1	0	0	1	1	0	1	0	0	29	64	4799	0.68181	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	117	118	2	2	1	0	0	0	2	0	0	29	118	4745	0.49157	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72312	rRNA processing	117	118	2	2	1	0	0	0	2	0	0	29	118	4745	0.49157	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72766	Translation	141	145	5	3	0	5	5	3	5	0	0	29	145	4718	0.41682	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8868773	rRNA processing in the nucleus and cytosol	117	118	2	2	1	0	0	0	2	0	0	29	118	4745	0.49157	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8953854	Metabolism of RNA	360	372	19	10	7	10	10	9	19	3	3	26	369	4494	0.82527	0.38089	0.4811	0.81	445170;394059;337461	polr2eb;cdc5l;nup35	ENSDARG00000026183;ENSDARG00000043797;ENSDARG00000012222		57.8474	50.7841	38.4902	23.692131805517203	49.947099131972394	17.44626508997519	28.1806	27.7952	23.5524	4.83244003377177	26.729822675887785	3.863426649881549	123.20453333333334	92.7866	62.902	79.97452490295478	95.76472523322334	57.57006961668631					50.7841;38.4902;84.2679	27.7952;23.5524;33.1942	92.7866;62.902;213.925	2	1	2	445170;394059	ENSDARG00000026183;ENSDARG00000043797	44.637150000000005	44.637150000000005	8.693100057229254	25.6738	25.6738	3.000112651218292	77.8443	77.8443	21.131603313047542	50.7841;38.4902	27.7952;23.5524	92.7866;62.902	1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,3(1)	4.2885879760297465	18.25138795375824	1.9996205568313599	13.281916618347168	6.252602831176095	2.969850778579712	31.037228995840753	84.65757100415925	22.712179313491937	33.64902068650807	32.70483891050793	213.70422775615873	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-199992	trans-Golgi Network Vesicle Budding	34	39	2	1	0	2	2	2	2	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-432720	Lysosome Vesicle Biogenesis	19	21	2	1	0	2	2	2	2	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	32	40	4	2	1	3	3	3	4	0	0	29	40	4823	0.78759	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-446203	Asparagine N-linked glycosylation	127	160	5	3	3	4	4	4	5	2	2	27	158	4705	0.93256	0.24485	0.24485	1.25	437015;394141	trappc1;dctn2	ENSDARG00000039005;ENSDARG00000031388		41.0187	41.0187	30.7771	14.48380962040028	36.38308732033343	12.915220915192597	23.96785	23.96785	20.0664	5.517483502920523	22.201952963493483	4.919943040108803	70.7442	70.7442	47.2048	33.28973873012523	60.08965958524612	29.68447812949984					51.2603;30.7771	27.8693;20.0664	94.2836;47.2048	0	2	0															2	437015;394141	ENSDARG00000039005;ENSDARG00000031388	41.0187	41.0187	14.48380962040028	23.96785	23.96785	5.517483502920523	70.7442	70.7442	33.28973873012523	51.2603;30.7771	27.8693;20.0664	94.2836;47.2048	0						Linear,2(1)	1.9319967501196054	3.9363808631896973	1.5924749374389648	2.3439059257507324	0.5313419474289602	1.9681904315948486	20.945164000000005	61.092236	16.321008	31.614691999999998	24.606976000000003	116.88142400000001	DOWN	0.0	1.0	0.0	
R-DRE-948021	Transport to the Golgi and subsequent modification	83	104	5	3	3	4	4	4	5	2	2	27	102	4761	0.97716	0.12557	0.12557	1.92	437015;394141	trappc1;dctn2	ENSDARG00000039005;ENSDARG00000031388		41.0187	41.0187	30.7771	14.48380962040028	36.38308732033343	12.915220915192597	23.96785	23.96785	20.0664	5.517483502920523	22.201952963493483	4.919943040108803	70.7442	70.7442	47.2048	33.28973873012523	60.08965958524612	29.68447812949984					51.2603;30.7771	27.8693;20.0664	94.2836;47.2048	0	2	0															2	437015;394141	ENSDARG00000039005;ENSDARG00000031388	41.0187	41.0187	14.48380962040028	23.96785	23.96785	5.517483502920523	70.7442	70.7442	33.28973873012523	51.2603;30.7771	27.8693;20.0664	94.2836;47.2048	0						Linear,2(1)	1.9319967501196054	3.9363808631896973	1.5924749374389648	2.3439059257507324	0.5313419474289602	1.9681904315948486	20.945164000000005	61.092236	16.321008	31.614691999999998	24.606976000000003	116.88142400000001	DOWN	0.0	1.0	0.0	
R-DRE-199977	ER to Golgi Anterograde Transport	70	82	5	3	3	4	4	4	5	2	2	27	80	4783	0.98788	0.084229	0.084229	2.44	437015;394141	trappc1;dctn2	ENSDARG00000039005;ENSDARG00000031388		41.0187	41.0187	30.7771	14.48380962040028	36.38308732033343	12.915220915192597	23.96785	23.96785	20.0664	5.517483502920523	22.201952963493483	4.919943040108803	70.7442	70.7442	47.2048	33.28973873012523	60.08965958524612	29.68447812949984					51.2603;30.7771	27.8693;20.0664	94.2836;47.2048	0	2	0															2	437015;394141	ENSDARG00000039005;ENSDARG00000031388	41.0187	41.0187	14.48380962040028	23.96785	23.96785	5.517483502920523	70.7442	70.7442	33.28973873012523	51.2603;30.7771	27.8693;20.0664	94.2836;47.2048	0						Linear,2(1)	1.9319967501196054	3.9363808631896973	1.5924749374389648	2.3439059257507324	0.5313419474289602	1.9681904315948486	20.945164000000005	61.092236	16.321008	31.614691999999998	24.606976000000003	116.88142400000001	DOWN	0.0	1.0	0.0	
R-DRE-204005	COPII-mediated vesicle transport	35	42	3	1	1	3	3	3	3	1	1	28	41	4822	0.97476	0.2218	0.2218	2.38	437015	trappc1	ENSDARG00000039005		51.2603	51.2603	51.2603		51.2603		27.8693	27.8693	27.8693		27.8693		94.2836	94.2836	94.2836		94.2836						51.2603	27.8693	94.2836	0	1	0															1	437015	ENSDARG00000039005	51.2603	51.2603		27.8693	27.8693		94.2836	94.2836		51.2603	27.8693	94.2836	0						Linear,1(1)	1.5924749374389648	1.5924749374389648	1.5924749374389648	1.5924749374389648	0.0	1.5924749374389648	51.2603	51.2603	27.8693	27.8693	94.2836	94.2836	DOWN	0.0	1.0	0.0	
R-DRE-2132295	MHC class II antigen presentation	20	43	1	0	0	1	1	1	1	0	0	29	43	4820	0.77354	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5694530	Cargo concentration in the ER	17	21	2	0	0	2	2	2	2	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196854	Metabolism of vitamins and cofactors	75	90	5	4	2	4	4	2	5	0	0	29	90	4773	0.58272	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6806667	Metabolism of fat-soluble vitamins	17	19	2	1	1	1	1	0	2	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9012999	RHO GTPase cycle	200	252	9	8	5	8	8	7	9	3	3	26	249	4614	0.94069	0.18572	0.18572	1.19	80963;751645;100005849	rnd3a;rnd2;rhov	ENSDARG00000076799;ENSDARG00000070735;ENSDARG00000070434		74.00556666666667	72.0116	60.6068	14.498949802083327	70.9673904304098	12.689312068850528	29.191466666666667	32.056	22.0961	6.182626062065654	28.47966906434389	6.222590088705522	189.04299999999998	166.237	161.769	43.428050336159565	178.40746926255665	36.427986788850056					72.0116;60.6068;89.3983	32.056;22.0961;33.4223	161.769;166.237;239.123	1	2	1	751645	ENSDARG00000070735	60.6068	60.6068		22.0961	22.0961		166.237	166.237		60.6068	22.0961	166.237	2	80963;100005849	ENSDARG00000076799;ENSDARG00000070434	80.70495	80.70495	12.294253472456262	32.739149999999995	32.739149999999995	0.9661199951355175	200.446	200.446	54.69753795190404	72.0116;89.3983	32.056;33.4223	161.769;239.123	0						Linear,3(1)	4.005360440546968	13.224725723266602	2.063920497894287	5.664744853973389	2.031993053190813	5.496060371398926	57.59846042711524	90.41267290621809	22.19516665705117	36.18776667628216	139.8995347581539	238.18646524184607	DOWN	0.3333333333333333	0.6666666666666666	0.0	
R-DRE-9696264	RND3 GTPase cycle	24	28	1	1	1	1	1	1	1	1	1	28	27	4836	0.98834	0.15375	0.15375	3.57	80963	rnd3a	ENSDARG00000076799		72.0116	72.0116	72.0116		72.0116		32.056	32.056	32.056		32.056		161.769	161.769	161.769		161.769						72.0116	32.056	161.769	0	1	0															1	80963	ENSDARG00000076799	72.0116	72.0116		32.056	32.056		161.769	161.769		72.0116	32.056	161.769	0						Linear,1(1)	2.063920497894287	2.063920497894287	2.063920497894287	2.063920497894287	0.0	2.063920497894287	72.0116	72.0116	32.056	32.056	161.769	161.769	DOWN	0.0	1.0	0.0	
R-DRE-9696270	RND2 GTPase cycle	20	27	1	1	1	1	1	1	1	1	1	28	26	4837	0.98913	0.14868	0.14868	3.7	751645	rnd2	ENSDARG00000070735		60.6068	60.6068	60.6068		60.60679999999999		22.0961	22.0961	22.0961		22.0961		166.237	166.237	166.237		166.237						60.6068	22.0961	166.237	1	0	1	751645	ENSDARG00000070735	60.6068	60.6068		22.0961	22.0961		166.237	166.237		60.6068	22.0961	166.237	0															0						Linear,1(1)	5.664744853973389	5.664744853973389	5.664744853973389	5.664744853973389	0.0	5.664744853973389	60.6068	60.6068	22.0961	22.0961	166.237	166.237	UP	1.0	0.0	0.0	
R-DRE-1630316	Glycosaminoglycan metabolism	40	78	2	2	0	2	2	2	2	0	0	29	78	4785	0.62659	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1793185	Chondroitin sulfate/dermatan sulfate metabolism	9	26	1	1	0	1	1	1	1	0	0	29	26	4837	0.85643	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2022870	Chondroitin sulfate biosynthesis	5	16	1	1	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71387	Metabolism of carbohydrates	100	148	3	3	0	2	2	2	3	0	0	29	148	4715	0.40922	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166016	Toll Like Receptor 4 (TLR4) Cascade	39	49	3	1	1	1	1	0	3	0	0	29	49	4814	0.74618	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166166	MyD88-independent TLR4 cascade 	37	45	3	1	1	1	1	0	3	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166520	Signaling by NTRKs	42	49	3	2	1	2	2	2	3	1	1	28	48	4815	0.9664	0.25382	0.25382	2.04	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-168138	Toll Like Receptor 9 (TLR9) Cascade	41	49	3	1	1	1	1	0	3	0	0	29	49	4814	0.74618	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168142	Toll Like Receptor 10 (TLR10) Cascade	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168164	Toll Like Receptor 3 (TLR3) Cascade	37	45	3	1	1	1	1	0	3	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168176	Toll Like Receptor 5 (TLR5) Cascade	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168179	Toll Like Receptor TLR1:TLR2 Cascade	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	39	47	3	1	1	1	1	0	3	0	0	29	47	4816	0.7552	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168188	Toll Like Receptor TLR6:TLR2 Cascade	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168898	Toll-like Receptor Cascades	45	60	3	1	1	1	1	0	3	0	0	29	60	4803	0.69843	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-181438	Toll Like Receptor 2 (TLR2) Cascade	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-187037	Signaling by NTRK1 (TRKA)	37	43	3	2	1	2	2	2	3	1	1	28	42	4821	0.97363	0.22646	0.22646	2.33	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-198725	Nuclear Events (kinase and transcription factor activation)	16	18	1	0	0	0	0	0	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-198753	ERK/MAPK targets	10	11	1	0	0	0	0	0	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-202670	ERKs are inactivated	9	9	1	0	0	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-448424	Interleukin-17 signaling	29	33	3	1	1	1	1	0	3	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-449147	Signaling by Interleukins	77	122	5	3	1	3	3	2	5	0	0	29	122	4741	0.47973	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450282	MAPK targets/ Nuclear events mediated by MAP kinases	17	18	1	0	0	0	0	0	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450294	MAP kinase activation	29	33	3	1	1	1	1	0	3	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-937061	TRIF(TICAM1)-mediated TLR4 signaling 	37	45	3	1	1	1	1	0	3	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975155	MyD88 dependent cascade initiated on endosome	39	47	3	1	1	1	1	0	3	0	0	29	47	4816	0.7552	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975871	MyD88 cascade initiated on plasma membrane	39	46	3	1	1	1	1	0	3	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3214841	PKMTs methylate histone lysines	21	33	1	0	0	1	1	0	1	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3247509	Chromatin modifying enzymes	77	100	4	3	2	2	2	1	4	0	0	29	100	4763	0.54844	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4839726	Chromatin organization	77	100	4	3	2	2	2	1	4	0	0	29	100	4763	0.54844	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693532	DNA Double-Strand Break Repair	72	90	7	4	2	5	5	4	7	1	1	28	89	4774	0.90129	0.41728	0.41728	1.11	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-5693538	Homology Directed Repair	56	74	5	2	1	4	4	3	5	1	1	28	73	4790	0.9295	0.35809	0.35809	1.35	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	35	42	4	3	2	3	3	2	4	1	1	28	41	4822	0.97476	0.2218	0.2218	2.38	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-5693567	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	52	69	4	1	1	3	3	2	4	1	1	28	68	4795	0.93765	0.33843	0.33843	1.45	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-5693571	Nonhomologous End-Joining (NHEJ)	27	34	2	1	1	2	2	1	2	1	1	28	33	4830	0.98307	0.18359	0.18359	2.94	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-5693606	DNA Double Strand Break Response	35	42	4	3	2	3	3	2	4	1	1	28	41	4822	0.97476	0.2218	0.2218	2.38	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-5693607	Processing of DNA double-strand break ends	36	50	3	1	1	2	2	1	3	1	1	28	49	4814	0.96513	0.25828	0.25828	2.0	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-69473	G2/M DNA damage checkpoint	44	57	2	1	1	2	2	1	2	1	1	28	56	4807	0.9557	0.28884	0.28884	1.75	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-69481	G2/M Checkpoints	88	107	6	3	2	5	5	4	6	1	1	28	106	4757	0.86846	0.47439	0.47439	0.93	404050	rnf8	ENSDARG00000044949		64.7888	64.7888	64.7888		64.7888		30.9207	30.9207	30.9207		30.9207		135.753	135.753	135.753		135.753						64.7888	30.9207	135.753	0	1	0															1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,1(1)	2.8268096446990967	2.8268096446990967	2.8268096446990967	2.8268096446990967	0.0	2.8268096446990967	64.7888	64.7888	30.9207	30.9207	135.753	135.753	DOWN	0.0	1.0	0.0	
R-DRE-73894	DNA Repair	148	177	12	6	4	8	8	6	12	2	2	27	175	4688	0.91441	0.28267	0.28267	1.13	445170;404050	polr2eb;rnf8	ENSDARG00000026183;ENSDARG00000044949		57.78645	57.78645	50.7841	9.902818338483169	55.628504274385975	9.420846646432917	29.357950000000002	29.357950000000002	27.7952	2.2100622445984817	28.87635029665708	2.1024981751431113	114.2698	114.2698	92.7866	30.3818328031736	107.64922553392627	28.90314432649761					50.7841;64.7888	27.7952;30.9207	92.7866;135.753	1	1	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	1	404050	ENSDARG00000044949	64.7888	64.7888		30.9207	30.9207		135.753	135.753		64.7888	30.9207	135.753	0						Linear,2(1)	2.377508501728115	4.8264302015304565	1.9996205568313599	2.8268096446990967	0.5849110133547916	2.4132151007652283	44.06184400000001	71.511056	26.294960000000003	32.42094	72.16272800000002	156.376872	CONFLICT	0.5	0.5	0.0	
R-DRE-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	37	46	5	2	1	5	5	3	5	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2029482	Regulation of actin dynamics for phagocytic cup formation	32	39	4	2	1	4	4	2	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-376176	Signaling by ROBO receptors	18	18	1	0	0	1	1	1	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-422475	Axon guidance	121	145	9	7	3	8	8	7	9	1	1	28	144	4719	0.78823	0.58318	0.58318	0.69	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5663213	RHO GTPases Activate WASPs and WAVEs	23	25	1	1	1	1	1	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69231	Cyclin D associated events in G1	29	32	2	0	0	1	1	1	2	0	0	29	32	4831	0.82624	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69236	G1 Phase	29	32	2	0	0	1	1	1	2	0	0	29	32	4831	0.82624	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8878171	Transcriptional regulation by RUNX1	99	134	7	5	4	3	3	3	7	0	0	29	134	4729	0.44584	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	48	54	4	2	1	3	3	3	4	0	0	29	54	4809	0.7241	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9675108	Nervous system development	122	146	9	7	3	8	8	7	9	1	1	28	145	4718	0.78604	0.58573	0.58573	0.68	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-112315	Transmission across Chemical Synapses	88	133	2	2	0	2	2	2	2	0	0	29	133	4730	0.44858	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112316	Neuronal System	116	208	4	3	1	4	4	3	4	0	0	29	208	4655	0.2826	1.0	0.63388	0.0																														0	0	0															0															0																							
R-DRE-71291	Metabolism of amino acids and derivatives	130	156	9	4	2	4	4	4	9	0	0	29	156	4707	0.38962	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-191859	snRNP Assembly	25	26	2	1	1	1	1	1	2	1	1	28	25	4838	0.9899	0.14357	0.14357	3.85	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-194441	Metabolism of non-coding RNA	25	26	2	1	1	1	1	1	2	1	1	28	25	4838	0.9899	0.14357	0.14357	3.85	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-390247	Beta-oxidation of very long chain fatty acids	6	9	1	1	0	1	1	1	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-390918	Peroxisomal lipid metabolism	12	17	2	2	0	2	2	2	2	0	0	29	17	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-556833	Metabolism of lipids	260	343	23	15	5	17	17	15	23	3	3	26	340	4523	0.85827	0.33253	0.45323	0.87	554095;403031;402943	fabp1b.1;rab4a;stard10	ENSDARG00000059227;ENSDARG00000019144;ENSDARG00000097718		34.95947533333334	44.1589	0.201926	31.19242204713872	43.394816123047896	29.272680470450563	18.612264933333332	25.6535	0.0364948	16.243209758459965	22.458717898623043	14.770242229637631	66.20524999999999	76.0135	1.11725	60.7803433361683	84.31203793840596	58.67793861054677					60.5176;0.201926;44.1589	30.1468;0.0364948;25.6535	121.485;1.11725;76.0135	2	1	2	554095;402943	ENSDARG00000059227;ENSDARG00000097718	52.33825	52.33825	11.567347701396397	27.90015	27.90015	3.1772428999055085	98.74924999999999	98.74924999999999	32.15320600072413	60.5176;44.1589	30.1468;25.6535	121.485;76.0135	1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(0.34);Linear,2(0.67)	Infinity	Infinity	1.5967966318130493	Infinity	NaN	NaN	-0.3380730672268939	70.25702373389356	0.23134274129451526	36.993187125372145	-2.57418326968633	134.98468326968631	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-8978868	Fatty acid metabolism	75	94	6	4	1	3	3	3	6	0	0	29	94	4769	0.56876	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9033241	Peroxisomal protein import	29	39	3	3	1	3	3	3	3	1	1	28	38	4825	0.97804	0.20768	0.20768	2.56	559933	pex14	ENSDARG00000028322		58.814	58.814	58.814		58.814		29.9372	29.9372	29.9372		29.9372		115.545	115.545	115.545		115.545						58.814	29.9372	115.545	1	0	1	559933	ENSDARG00000028322	58.814	58.814		29.9372	29.9372		115.545	115.545		58.814	29.9372	115.545	0															0						Linear,1(1)	2.1846325397491455	2.1846325397491455	2.1846325397491455	2.1846325397491455	0.0	2.1846325397491455	58.814	58.814	29.9372	29.9372	115.545	115.545	UP	1.0	0.0	0.0	
R-DRE-9609507	Protein localization	57	75	7	5	2	7	7	5	7	1	1	28	74	4789	0.92783	0.36195	0.36195	1.33	559933	pex14	ENSDARG00000028322		58.814	58.814	58.814		58.814		29.9372	29.9372	29.9372		29.9372		115.545	115.545	115.545		115.545						58.814	29.9372	115.545	1	0	1	559933	ENSDARG00000028322	58.814	58.814		29.9372	29.9372		115.545	115.545		58.814	29.9372	115.545	0															0						Linear,1(1)	2.1846325397491455	2.1846325397491455	2.1846325397491455	2.1846325397491455	0.0	2.1846325397491455	58.814	58.814	29.9372	29.9372	115.545	115.545	UP	1.0	0.0	0.0	
R-DRE-166658	Complement cascade	19	26	2	2	1	1	1	1	2	1	1	28	25	4838	0.9899	0.14357	0.14357	3.85	553553	cfd	ENSDARG00000039579		58.5336	58.5336	58.5336		58.5336		29.7061	29.7061	29.7061		29.7061		115.336	115.336	115.336		115.33599999999998						58.5336	29.7061	115.336	0	1	0															1	553553	ENSDARG00000039579	58.5336	58.5336		29.7061	29.7061		115.336	115.336		58.5336	29.7061	115.336	0						Linear,1(1)	1.672296166419983	1.672296166419983	1.672296166419983	1.672296166419983	0.0	1.672296166419983	58.5336	58.5336	29.7061	29.7061	115.336	115.336	DOWN	0.0	1.0	0.0	
R-DRE-2022377	Metabolism of Angiotensinogen to Angiotensins	10	13	1	1	0	1	1	1	1	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2980736	Peptide hormone metabolism	27	40	5	5	4	2	2	1	5	0	0	29	40	4823	0.78759	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-977606	Regulation of Complement cascade	17	23	1	1	0	0	0	0	1	0	0	29	23	4840	0.87192	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2262752	Cellular responses to stress	280	336	18	12	7	14	14	12	18	4	4	25	332	4531	0.95497	0.13419	0.13419	1.19	554095;550576;394141;337461	fabp1b.1;anapc16;dctn2;nup35	ENSDARG00000059227;ENSDARG00000013822;ENSDARG00000031388;ENSDARG00000012222		61.3022	65.08189999999999	30.7771	22.579068770729513	54.55379162118459	21.35441412749536	28.777500000000003	30.9247	20.0664	5.939183294022821	27.312852568783086	6.1131134338236865	133.90445	137.244	47.2048	69.37606475538475	111.71818945927636	62.10460601958789					60.5176;69.6462;30.7771;84.2679	30.1468;31.7026;20.0664;33.1942	121.485;153.003;47.2048;213.925	1	3	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	3	550576;394141;337461	ENSDARG00000013822;ENSDARG00000031388;ENSDARG00000012222	61.563733333333325	69.6462	27.64617734377275	28.321066666666667	31.7026	7.187548884935215	138.04426666666666	153.003	84.36070797008132	69.6462;30.7771;84.2679	31.7026;20.0664;33.1942	153.003;47.2048;213.925	0						Linear,4(1)	3.0567872325985364	18.978966116905212	1.5967966318130493	13.281916618347168	5.7005096084866675	2.0501264333724976	39.17471260468507	83.42968739531493	22.95710037185762	34.597899628142386	65.91590653972297	201.892993460277	DOWN	0.25	0.75	0.0	
R-DRE-8953897	Cellular responses to stimuli	280	336	18	12	7	14	14	12	18	4	4	25	332	4531	0.95497	0.13419	0.13419	1.19	554095;550576;394141;337461	fabp1b.1;anapc16;dctn2;nup35	ENSDARG00000059227;ENSDARG00000013822;ENSDARG00000031388;ENSDARG00000012222		61.3022	65.08189999999999	30.7771	22.579068770729513	54.55379162118459	21.35441412749536	28.777500000000003	30.9247	20.0664	5.939183294022821	27.312852568783086	6.1131134338236865	133.90445	137.244	47.2048	69.37606475538475	111.71818945927636	62.10460601958789					60.5176;69.6462;30.7771;84.2679	30.1468;31.7026;20.0664;33.1942	121.485;153.003;47.2048;213.925	1	3	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	3	550576;394141;337461	ENSDARG00000013822;ENSDARG00000031388;ENSDARG00000012222	61.563733333333325	69.6462	27.64617734377275	28.321066666666667	31.7026	7.187548884935215	138.04426666666666	153.003	84.36070797008132	69.6462;30.7771;84.2679	31.7026;20.0664;33.1942	153.003;47.2048;213.925	0						Linear,4(1)	3.0567872325985364	18.978966116905212	1.5967966318130493	13.281916618347168	5.7005096084866675	2.0501264333724976	39.17471260468507	83.42968739531493	22.95710037185762	34.597899628142386	65.91590653972297	201.892993460277	DOWN	0.25	0.75	0.0	
R-DRE-9707564	Cytoprotection by HMOX1	72	84	6	4	2	5	5	5	6	1	1	28	83	4780	0.91222	0.39573	0.39573	1.19	554095	fabp1b.1	ENSDARG00000059227		60.5176	60.5176	60.5176		60.5176		30.1468	30.1468	30.1468		30.1468		121.485	121.485	121.485		121.485						60.5176	30.1468	121.485	1	0	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	0															0						Linear,1(1)	1.5967966318130493	1.5967966318130493	1.5967966318130493	1.5967966318130493	0.0	1.5967966318130493	60.5176	60.5176	30.1468	30.1468	121.485	121.485	UP	1.0	0.0	0.0	
R-DRE-9711123	Cellular response to chemical stress	87	101	6	4	2	5	5	5	6	1	1	28	100	4763	0.88033	0.45488	0.45488	0.99	554095	fabp1b.1	ENSDARG00000059227		60.5176	60.5176	60.5176		60.5176		30.1468	30.1468	30.1468		30.1468		121.485	121.485	121.485		121.485						60.5176	30.1468	121.485	1	0	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	0															0						Linear,1(1)	1.5967966318130493	1.5967966318130493	1.5967966318130493	1.5967966318130493	0.0	1.5967966318130493	60.5176	60.5176	30.1468	30.1468	121.485	121.485	UP	1.0	0.0	0.0	
R-DRE-9013148	CDC42 GTPase cycle	62	85	2	2	1	1	1	1	2	0	0	29	85	4778	0.60062	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013149	RAC1 GTPase cycle	64	91	1	1	0	1	1	1	1	0	0	29	91	4772	0.5792	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983231	Factors involved in megakaryocyte development and platelet production	63	82	3	1	0	2	2	2	3	0	0	29	82	4781	0.61162	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1474228	Degradation of the extracellular matrix	37	59	3	3	0	2	2	2	3	0	0	29	59	4804	0.70265	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1474244	Extracellular matrix organization	92	129	3	3	0	2	2	2	3	0	0	29	129	4734	0.45967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1592389	Activation of Matrix Metalloproteinases	16	31	3	3	0	2	2	2	3	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-446652	Interleukin-1 family signaling	29	41	2	1	1	1	1	0	2	0	0	29	41	4822	0.78288	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6803157	Antimicrobial peptides	18	27	2	2	0	1	1	1	2	0	0	29	27	4836	0.85132	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	27	39	3	2	1	2	2	1	3	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-622312	Inflammasomes	7	14	1	1	0	1	1	1	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-844455	The NLRP1 inflammasome	2	3	1	1	0	1	1	1	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6804756	Regulation of TP53 Activity through Phosphorylation	50	60	2	0	0	1	1	0	2	0	0	29	60	4803	0.69843	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9663891	Selective autophagy	39	46	1	0	0	1	1	0	1	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8852135	Protein ubiquitination	44	48	2	1	1	2	2	1	2	1	1	28	47	4816	0.96765	0.24932	0.24932	2.08	559933	pex14	ENSDARG00000028322		58.814	58.814	58.814		58.814		29.9372	29.9372	29.9372		29.9372		115.545	115.545	115.545		115.545						58.814	29.9372	115.545	1	0	1	559933	ENSDARG00000028322	58.814	58.814		29.9372	29.9372		115.545	115.545		58.814	29.9372	115.545	0															0						Linear,1(1)	2.1846325397491455	2.1846325397491455	2.1846325397491455	2.1846325397491455	0.0	2.1846325397491455	58.814	58.814	29.9372	29.9372	115.545	115.545	UP	1.0	0.0	0.0	
R-DRE-5696395	Formation of Incision Complex in GG-NER	32	34	4	1	0	3	3	1	4	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5696398	Nucleotide Excision Repair	71	74	8	2	1	6	6	4	8	1	1	28	73	4790	0.9295	0.35809	0.35809	1.35	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	51	54	5	1	0	4	4	2	5	0	0	29	54	4809	0.7241	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5696400	Dual Incision in GG-NER	22	24	2	1	0	2	2	2	2	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	48	50	4	1	1	3	3	3	4	1	1	28	49	4814	0.96513	0.25828	0.25828	2.0	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6782135	Dual incision in TC-NER	41	43	4	1	1	3	3	3	4	1	1	28	42	4821	0.97363	0.22646	0.22646	2.33	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-5688426	Deubiquitination	130	156	11	5	3	8	8	6	11	0	0	29	156	4707	0.38962	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5689880	Ub-specific processing proteases	101	119	11	5	3	8	8	6	11	0	0	29	119	4744	0.48859	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111885	Opioid Signalling	38	49	2	0	0	0	0	0	2	0	0	29	49	4814	0.74618	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1483249	Inositol phosphate metabolism	17	21	1	1	0	1	1	1	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163685	Integration of energy metabolism	39	52	2	2	1	2	2	1	2	0	0	29	52	4811	0.73286	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1855204	Synthesis of IP3 and IP4 in the cytosol	8	9	1	1	0	1	1	1	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-195721	Signaling by WNT	158	199	8	4	3	4	4	4	8	0	0	29	199	4664	0.29883	1.0	0.63032	0.0																														0	0	0															0															0																							
R-DRE-3858494	Beta-catenin independent WNT signaling	82	92	4	2	1	3	3	3	4	0	0	29	92	4771	0.5757	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-400451	Free fatty acids regulate insulin secretion	5	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-422356	Regulation of insulin secretion	31	41	2	2	1	2	2	1	2	0	0	29	41	4822	0.78288	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1483191	Synthesis of PC	13	16	3	2	1	2	2	1	3	1	1	28	15	4848	0.99613	0.090879	0.090879	6.25	402943	stard10	ENSDARG00000097718		44.1589	44.1589	44.1589		44.1589		25.6535	25.6535	25.6535		25.6535		76.0135	76.0135	76.0135		76.0135		0.0	44.1589			44.1589	25.6535	76.0135	1	0	1	402943	ENSDARG00000097718	44.1589	44.1589		25.6535	25.6535		76.0135	76.0135		44.1589	25.6535	76.0135	0															0						Linear,1(1)	3.145048856735229	3.1450488567352295	3.1450488567352295	3.1450488567352295	0.0	3.1450488567352295	44.1589	44.1589	25.6535	25.6535	76.0135	76.0135	UP	1.0	0.0	0.0	
R-DRE-1483206	Glycerophospholipid biosynthesis	49	68	4	2	1	3	3	2	4	1	1	28	67	4796	0.93924	0.33443	0.33443	1.47	402943	stard10	ENSDARG00000097718		44.1589	44.1589	44.1589		44.1589		25.6535	25.6535	25.6535		25.6535		76.0135	76.0135	76.0135		76.0135						44.1589	25.6535	76.0135	1	0	1	402943	ENSDARG00000097718	44.1589	44.1589		25.6535	25.6535		76.0135	76.0135		44.1589	25.6535	76.0135	0															0						Linear,1(1)	3.145048856735229	3.1450488567352295	3.1450488567352295	3.1450488567352295	0.0	3.1450488567352295	44.1589	44.1589	25.6535	25.6535	76.0135	76.0135	UP	1.0	0.0	0.0	
R-DRE-1483257	Phospholipid metabolism	80	108	9	5	2	7	7	6	9	2	2	27	106	4757	0.97479	0.13355	0.13355	1.85	403031;402943	rab4a;stard10	ENSDARG00000019144;ENSDARG00000097718		22.180413	22.180413	0.201926	31.08227439584076	22.84205567369314	31.068186937171507	12.8449974	12.8449974	0.0364948	18.11395809061105	13.230585903260916	18.105748278398202	38.565374999999996	38.565374999999996	1.11725	52.95964626044296	39.69271727564412	52.93564329276013					0.201926;44.1589	0.0364948;25.6535	1.11725;76.0135	1	1	1	402943	ENSDARG00000097718	44.1589	44.1589		25.6535	25.6535		76.0135	76.0135		44.1589	25.6535	76.0135	1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(0.5);Linear,1(0.5)	Infinity	Infinity	3.1450488567352295	Infinity	NaN	Infinity	-20.897421519999995	65.25824752	-12.259667695999998	37.949662496	-34.83294999999999	111.96369999999999	CONFLICT	0.5	0.5	0.0	
R-DRE-5423646	Aflatoxin activation and detoxification	8	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418555	G alpha (s) signalling events	30	102	1	1	1	1	1	0	1	0	0	29	102	4761	0.54182	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73887	Death Receptor Signalling	52	78	3	3	3	1	1	1	3	1	1	28	77	4786	0.92273	0.37341	0.37341	1.28	550506	nsmaf	ENSDARG00000051920		40.6531	40.6531	40.6531		40.6531		24.4822	24.4822	24.4822		24.482199999999995		67.5052	67.5052	67.5052		67.5052						40.6531	24.4822	67.5052	0	1	0															1	550506	ENSDARG00000051920	40.6531	40.6531		24.4822	24.4822		67.5052	67.5052		40.6531	24.4822	67.5052	0						Linear,1(1)	11.86266231536865	11.862662315368652	11.862662315368652	11.862662315368652	0.0	11.862662315368652	40.6531	40.6531	24.4822	24.4822	67.5052	67.5052	DOWN	0.0	1.0	0.0	
R-DRE-75893	TNF signaling	23	31	1	1	1	1	1	1	1	1	1	28	30	4833	0.98581	0.1688	0.1688	3.23	550506	nsmaf	ENSDARG00000051920		40.6531	40.6531	40.6531		40.6531		24.4822	24.4822	24.4822		24.482199999999995		67.5052	67.5052	67.5052		67.5052						40.6531	24.4822	67.5052	0	1	0															1	550506	ENSDARG00000051920	40.6531	40.6531		24.4822	24.4822		67.5052	67.5052		40.6531	24.4822	67.5052	0						Linear,1(1)	11.86266231536865	11.862662315368652	11.862662315368652	11.862662315368652	0.0	11.862662315368652	40.6531	40.6531	24.4822	24.4822	67.5052	67.5052	DOWN	0.0	1.0	0.0	
R-DRE-3371453	Regulation of HSF1-mediated heat shock response	43	45	3	2	1	2	2	2	3	1	1	28	44	4819	0.9713	0.23568	0.23568	2.22	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-3371556	Cellular response to heat stress	57	60	4	3	1	3	3	3	4	1	1	28	59	4804	0.9514	0.30157	0.30157	1.67	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-350562	Regulation of ornithine decarboxylase (ODC)	36	39	4	2	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-351202	Metabolism of polyamines	41	44	4	2	1	3	3	3	4	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-189445	Metabolism of porphyrins	10	16	4	4	3	4	4	3	4	2	2	27	14	4849	0.9999	0.0038679	0.0038679	12.5	554095;553384	fabp1b.1;cox10	ENSDARG00000059227;ENSDARG00000034309		58.9263	58.9263	57.335	2.2504380418043537	59.763465956570165	1.9138384734144167	29.85025	29.85025	29.5537	0.4193850319217559	30.006261791881403	0.3566573237551311	116.35849999999999	116.35849999999999	111.232	7.249965827505895	119.05549696874064	6.165583443697918	0.0	57.335	0.5	58.9263	60.5176;57.335	30.1468;29.5537	121.485;111.232	1	1	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	1	553384	ENSDARG00000034309	57.335	57.335		29.5537	29.5537		111.232	111.232		57.335	29.5537	111.232	0						Linear,2(1)	1.8272855046886762	3.6878408193588257	1.5967966318130493	2.0910441875457764	0.34948579824348736	1.8439204096794128	55.807351999999995	62.045248	29.269012	30.431487999999998	106.31056	126.40643999999999	CONFLICT	0.5	0.5	0.0	
R-DRE-189483	Heme degradation	5	11	2	2	2	2	2	1	2	1	1	28	10	4853	0.99819	0.063373	0.063373	9.09	554095	fabp1b.1	ENSDARG00000059227		60.5176	60.5176	60.5176		60.5176		30.1468	30.1468	30.1468		30.1468		121.485	121.485	121.485		121.485		0.0	60.5176			60.5176	30.1468	121.485	1	0	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	0															0						Linear,1(1)	1.5967966318130493	1.5967966318130493	1.5967966318130493	1.5967966318130493	0.0	1.5967966318130493	60.5176	60.5176	30.1468	30.1468	121.485	121.485	UP	1.0	0.0	0.0	
R-DRE-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	12	13	2	2	0	2	2	2	2	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196849	Metabolism of water-soluble vitamins and cofactors	51	64	3	3	1	3	3	2	3	0	0	29	64	4799	0.68181	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-382556	ABC-family proteins mediated transport	54	65	5	2	1	3	3	3	5	0	0	29	65	4798	0.67772	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5173105	O-linked glycosylation	35	52	3	3	1	3	3	2	3	0	0	29	52	4811	0.73286	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-913709	O-linked glycosylation of mucins	20	29	2	2	1	2	2	1	2	0	0	29	29	4834	0.8412	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-380095	Tachykinin receptors bind tachykinins	2	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-186763	Downstream signal transduction	16	18	3	2	1	3	3	3	3	1	1	28	17	4846	0.9951	0.10166	0.10166	5.56	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-186797	Signaling by PDGF	26	30	3	2	1	3	3	3	3	1	1	28	29	4834	0.98668	0.16381	0.16381	3.33	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-2682334	EPH-Ephrin signaling	46	53	2	2	2	2	2	1	2	1	1	28	52	4811	0.96119	0.27153	0.27153	1.89	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-3928662	EPHB-mediated forward signaling	26	29	2	2	2	2	2	1	2	1	1	28	28	4835	0.98752	0.1588	0.1588	3.45	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5218921	VEGFR2 mediated cell proliferation	9	11	1	1	1	1	1	1	1	1	1	28	10	4853	0.99819	0.063373	0.063373	9.09	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5658442	Regulation of RAS by GAPs	43	48	6	3	2	4	4	4	6	1	1	28	47	4816	0.96765	0.24932	0.24932	2.08	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-8848021	Signaling by PTK6	25	26	2	2	1	2	2	2	2	1	1	28	25	4838	0.9899	0.14357	0.14357	3.85	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	8	8	2	2	1	2	2	2	2	1	1	28	7	4856	0.99907	0.046485	0.046485	12.5	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-9006927	Signaling by Non-Receptor Tyrosine Kinases	25	26	2	2	1	2	2	2	2	1	1	28	25	4838	0.9899	0.14357	0.14357	3.85	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	18	22	2	1	1	1	1	0	2	0	0	29	22	4841	0.87714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9020702	Interleukin-1 signaling	21	28	2	1	1	1	1	0	2	0	0	29	28	4835	0.84625	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6811438	Intra-Golgi traffic	18	20	1	1	0	1	1	1	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	82	100	4	2	0	3	3	3	4	0	0	29	100	4763	0.54844	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112310	Neurotransmitter release cycle	28	41	2	2	0	2	2	2	2	0	0	29	41	4822	0.78288	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-352230	Amino acid transport across the plasma membrane	20	29	1	0	0	1	1	0	1	0	0	29	29	4834	0.8412	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425366	Transport of bile salts and organic acids, metal ions and amine compounds	19	39	2	2	1	1	1	1	2	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	42	62	1	0	0	1	1	0	1	0	0	29	62	4801	0.69007	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425407	SLC-mediated transmembrane transport	73	121	3	2	1	2	2	1	3	0	0	29	121	4742	0.48267	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-888590	GABA synthesis, release, reuptake and degradation	15	21	1	1	0	1	1	1	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983705	Signaling by the B Cell Receptor (BCR)	49	59	5	3	2	4	4	4	5	1	1	28	58	4805	0.95285	0.29735	0.29735	1.69	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-674695	RNA Polymerase II Pre-transcription Events	48	48	7	2	2	5	5	3	7	1	1	28	47	4816	0.96765	0.24932	0.24932	2.08	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-73776	RNA Polymerase II Promoter Escape	34	34	5	2	2	3	3	2	5	1	1	28	33	4830	0.98307	0.18359	0.18359	2.94	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	34	34	5	2	2	3	3	2	5	1	1	28	33	4830	0.98307	0.18359	0.18359	2.94	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-75953	RNA Polymerase II Transcription Initiation	34	34	5	2	2	3	3	2	5	1	1	28	33	4830	0.98307	0.18359	0.18359	2.94	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	34	34	5	2	2	3	3	2	5	1	1	28	33	4830	0.98307	0.18359	0.18359	2.94	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-1483255	PI Metabolism	32	41	5	3	1	4	4	4	5	1	1	28	40	4823	0.97588	0.21712	0.21712	2.44	403031	rab4a	ENSDARG00000019144		0.201926	0.201926	0.201926		0.201926		0.0364948	0.0364948	0.0364948		0.0364948		1.11725	1.11725	1.11725		1.11725						0.201926	0.0364948	1.11725	0	1	0															1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(1)	Infinity	Infinity	Infinity	Infinity	0.0	Infinity	0.201926	0.201926	0.0364948	0.0364948	1.11725	1.11725	DOWN	0.0	1.0	0.0	
R-DRE-1660499	Synthesis of PIPs at the plasma membrane	19	25	4	2	1	3	3	3	4	1	1	28	24	4839	0.99064	0.13844	0.13844	4.0	403031	rab4a	ENSDARG00000019144		0.201926	0.201926	0.201926		0.201926		0.0364948	0.0364948	0.0364948		0.0364948		1.11725	1.11725	1.11725		1.11725						0.201926	0.0364948	1.11725	0	1	0															1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(1)	Infinity	Infinity	Infinity	Infinity	0.0	Infinity	0.201926	0.201926	0.0364948	0.0364948	1.11725	1.11725	DOWN	0.0	1.0	0.0	
R-DRE-202733	Cell surface interactions at the vascular wall	38	57	2	1	1	2	2	1	2	1	1	28	56	4807	0.9557	0.28884	0.28884	1.75	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-2029485	Role of phospholipids in phagocytosis	7	14	1	0	0	1	1	1	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-210993	Tie2 Signaling	6	8	1	1	1	1	1	1	1	1	1	28	7	4856	0.99907	0.046485	0.046485	12.5	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	15	21	1	1	0	1	1	1	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8853659	RET signaling	16	22	1	1	0	1	1	1	1	0	0	29	22	4841	0.87714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9006335	Signaling by Erythropoietin	4	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9027276	Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	4	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-912631	Regulation of signaling by CBL	13	15	1	1	0	1	1	1	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1614635	Sulfur amino acid metabolism	11	11	1	0	0	0	0	0	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168638	NOD1/2 Signaling Pathway	20	25	2	1	1	1	1	0	2	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373752	Netrin-1 signaling	14	19	2	1	1	1	1	1	2	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6794361	Neurexins and neuroligins	10	14	1	1	1	1	1	0	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6794362	Protein-protein interactions at synapses	24	38	2	1	1	2	2	1	2	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1483213	Synthesis of PE	6	6	1	1	0	0	0	0	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5687128	MAPK6/MAPK4 signaling	51	56	5	3	2	3	3	3	5	0	0	29	56	4807	0.71545	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6806834	Signaling by MET	43	47	5	5	3	4	4	4	5	2	2	27	45	4818	0.99745	0.031112	0.031112	4.26	553656;403031	hrasb;rab4a	ENSDARG00000005651;ENSDARG00000019144		20.980463	20.980463	0.201926	29.38528883167116	26.048945029183056	28.497652176283484	12.3884474	12.3884474	0.0364948	17.468298888709615	15.401443443870699	16.940636816381264	35.800925	35.800925	1.11725	49.05012357794066	44.2612696067221	47.56847444770819					41.759;0.201926	24.7404;0.0364948	70.4846;1.11725	1	1	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(0.5);Linear,1(0.5)	Infinity	Infinity	4.171412944793701	Infinity	NaN	Infinity	-19.74546952	61.70639552	-11.821379696000001	36.598274496	-32.179078	103.78092799999999	CONFLICT	0.5	0.5	0.0	
R-DRE-8854214	TBC/RABGAPs	22	28	1	1	1	1	1	1	1	1	1	28	27	4836	0.98834	0.15375	0.15375	3.57	403031	rab4a	ENSDARG00000019144		0.201926	0.201926	0.201926		0.201926		0.0364948	0.0364948	0.0364948		0.0364948		1.11725	1.11725	1.11725		1.11725						0.201926	0.0364948	1.11725	0	1	0															1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(1)	Infinity	Infinity	Infinity	Infinity	0.0	Infinity	0.201926	0.201926	0.0364948	0.0364948	1.11725	1.11725	DOWN	0.0	1.0	0.0	
R-DRE-8856828	Clathrin-mediated endocytosis	71	84	7	7	1	7	7	6	7	0	0	29	84	4779	0.60427	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8875656	MET receptor recycling	9	11	3	3	1	3	3	3	3	1	1	28	10	4853	0.99819	0.063373	0.063373	9.09	403031	rab4a	ENSDARG00000019144		0.201926	0.201926	0.201926		0.201926		0.0364948	0.0364948	0.0364948		0.0364948		1.11725	1.11725	1.11725		1.11725		0.0	0.201926			0.201926	0.0364948	1.11725	0	1	0															1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(1)	Infinity	Infinity	Infinity	Infinity	0.0	Infinity	0.201926	0.201926	0.0364948	0.0364948	1.11725	1.11725	DOWN	0.0	1.0	0.0	
R-DRE-2454202	Fc epsilon receptor (FCERI) signaling	33	43	2	1	1	1	1	0	2	0	0	29	43	4820	0.77354	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2871837	FCERI mediated NF-kB activation	19	26	2	1	1	1	1	0	2	0	0	29	26	4837	0.85643	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3214847	HATs acetylate histones	17	34	1	1	0	1	1	1	1	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9648002	RAS processing	11	13	1	1	1	1	1	1	1	1	1	28	12	4851	0.99746	0.07447	0.07447	7.69	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-429914	Deadenylation-dependent mRNA decay	32	33	1	1	0	1	1	1	1	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	57	60	4	2	1	3	3	3	4	0	0	29	60	4803	0.69843	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8932339	ROS sensing by NFE2L2	36	39	4	2	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8951664	Neddylation	117	144	13	7	2	10	10	8	13	1	1	28	143	4720	0.79042	0.58062	0.58062	0.69	378451	fbxl3a	ENSDARG00000103505		41.3714	41.3714	41.3714		41.3714		24.6021	24.6021	24.6021		24.6021		69.571	69.571	69.571		69.571						41.3714	24.6021	69.571	1	0	1	378451	ENSDARG00000103505	41.3714	41.3714		24.6021	24.6021		69.571	69.571		41.3714	24.6021	69.571	0															0						Linear,1(1)	3.3780648708343506	3.3780648708343506	3.3780648708343506	3.3780648708343506	0.0	3.3780648708343506	41.3714	41.3714	24.6021	24.6021	69.571	69.571	UP	1.0	0.0	0.0	
R-DRE-9707587	Regulation of HMOX1 expression and activity	41	45	4	2	1	3	3	3	4	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1369007	Mitochondrial ABC transporters	3	4	1	0	0	0	0	0	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-157579	Telomere Maintenance	32	45	1	1	1	0	0	0	1	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73886	Chromosome Maintenance	47	63	2	2	2	0	0	0	2	0	0	29	63	4800	0.68593	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-210991	Basigin interactions	14	19	1	0	0	1	1	0	1	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373080	Class B/2 (Secretin family receptors)	24	38	1	1	1	1	1	0	1	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-212676	Dopamine Neurotransmitter Release Cycle	12	14	1	1	0	1	1	1	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	42	43	3	2	2	1	1	1	3	1	1	28	42	4821	0.97363	0.22646	0.22646	2.33	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-72187	mRNA 3'-end processing	35	36	1	1	1	0	0	0	1	0	0	29	36	4827	0.80669	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72202	Transport of Mature Transcript to Cytoplasm	42	43	3	2	2	1	1	1	3	1	1	28	42	4821	0.97363	0.22646	0.22646	2.33	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-72203	Processing of Capped Intron-Containing Pre-mRNA	152	157	13	6	5	7	7	6	13	3	3	26	154	4709	0.98703	0.064446	0.064446	1.91	445170;394059;337461	polr2eb;cdc5l;nup35	ENSDARG00000026183;ENSDARG00000043797;ENSDARG00000012222		57.8474	50.7841	38.4902	23.692131805517203	49.947099131972394	17.44626508997519	28.1806	27.7952	23.5524	4.83244003377177	26.729822675887785	3.863426649881549	123.20453333333334	92.7866	62.902	79.97452490295478	95.76472523322334	57.57006961668631					50.7841;38.4902;84.2679	27.7952;23.5524;33.1942	92.7866;62.902;213.925	2	1	2	445170;394059	ENSDARG00000026183;ENSDARG00000043797	44.637150000000005	44.637150000000005	8.693100057229254	25.6738	25.6738	3.000112651218292	77.8443	77.8443	21.131603313047542	50.7841;38.4902	27.7952;23.5524	92.7866;62.902	1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,3(1)	4.2885879760297465	18.25138795375824	1.9996205568313599	13.281916618347168	6.252602831176095	2.969850778579712	31.037228995840753	84.65757100415925	22.712179313491937	33.64902068650807	32.70483891050793	213.70422775615873	UP	0.6666666666666666	0.3333333333333333	0.0	
R-DRE-1502540	Signaling by Activin	4	7	1	0	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9006936	Signaling by TGFB family members	43	55	5	3	1	4	4	3	5	0	0	29	55	4808	0.71976	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1483101	Synthesis of PS	1	1	1	0	0	1	1	1	1	0	0	29	1	4862	0.99407	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159418	Recycling of bile acids and salts	5	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-192105	Synthesis of bile acids and bile salts	16	20	1	1	0	1	1	1	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	12	13	1	1	0	1	1	1	1	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-194068	Bile acid and bile salt metabolism	17	21	1	1	0	1	1	1	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8957322	Metabolism of steroids	48	62	5	3	0	4	4	4	5	0	0	29	62	4801	0.69007	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5607761	Dectin-1 mediated noncanonical NF-kB signaling	35	40	4	2	1	3	3	3	4	0	0	29	40	4823	0.78759	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5607764	CLEC7A (Dectin-1) signaling	44	53	6	3	2	4	4	3	6	0	0	29	53	4810	0.72847	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5621481	C-type lectin receptors (CLRs)	50	61	7	4	3	5	5	4	7	1	1	28	60	4803	0.94994	0.30576	0.30576	1.64	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5668541	TNFR2 non-canonical NF-kB pathway	39	59	4	2	1	3	3	3	4	0	0	29	59	4804	0.70265	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5676590	NIK-->noncanonical NF-kB signaling	35	40	4	2	1	3	3	3	4	0	0	29	40	4823	0.78759	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373755	Semaphorin interactions	23	30	2	2	0	2	2	2	2	0	0	29	30	4833	0.83619	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-400685	Sema4D in semaphorin signaling	10	10	1	1	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8980692	RHOA GTPase cycle	60	77	1	0	0	1	1	1	1	0	0	29	77	4786	0.63039	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013106	RHOC GTPase cycle	34	39	2	1	0	2	2	2	2	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013408	RHOG GTPase cycle	34	40	1	1	1	0	0	0	1	0	0	29	40	4823	0.78759	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-140342	Apoptosis induced DNA fragmentation	13	16	2	1	0	2	2	2	2	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559583	Cellular Senescence	87	112	5	3	2	4	4	3	5	1	1	28	111	4752	0.85836	0.49014	0.49014	0.89	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	16	19	3	1	0	3	3	2	3	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559586	DNA Damage/Telomere Stress Induced Senescence	34	48	4	2	1	3	3	2	4	0	0	29	48	4815	0.75068	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-75153	Apoptotic execution phase	28	34	2	1	0	2	2	2	2	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2024101	CS/DS degradation	4	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2142845	Hyaluronan metabolism	5	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2160916	Hyaluronan uptake and degradation	4	8	1	1	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983712	Ion channel transport	44	65	1	1	0	1	1	1	1	0	0	29	65	4798	0.67772	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166663	Initial triggering of complement	5	8	1	1	1	1	1	1	1	1	1	28	7	4856	0.99907	0.046485	0.046485	12.5	553553	cfd	ENSDARG00000039579		58.5336	58.5336	58.5336		58.5336		29.7061	29.7061	29.7061		29.7061		115.336	115.336	115.336		115.33599999999998		0.0	58.5336	0.0	58.5336	58.5336	29.7061	115.336	0	1	0															1	553553	ENSDARG00000039579	58.5336	58.5336		29.7061	29.7061		115.336	115.336		58.5336	29.7061	115.336	0						Linear,1(1)	1.672296166419983	1.672296166419983	1.672296166419983	1.672296166419983	0.0	1.672296166419983	58.5336	58.5336	29.7061	29.7061	115.336	115.336	DOWN	0.0	1.0	0.0	
R-DRE-114508	Effects of PIP2 hydrolysis	8	12	2	1	1	2	2	2	2	1	1	28	11	4852	0.99784	0.068937	0.068937	8.33	767657	abhd12	ENSDARG00000071004		84.515	84.515	84.515		84.515		33.067	33.067	33.067		33.067		216.009	216.009	216.009		216.009		0.0	84.515			84.515	33.067	216.009	0	1	0															1	767657	ENSDARG00000071004	84.515	84.515		33.067	33.067		216.009	216.009		84.515	33.067	216.009	0						Linear,1(1)	2.24393630027771	2.24393630027771	2.24393630027771	2.24393630027771	0.0	2.24393630027771	84.515	84.515	33.067	33.067	216.009	216.009	DOWN	0.0	1.0	0.0	
R-DRE-1250196	SHC1 events in ERBB2 signaling	6	6	1	0	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1489509	DAG and IP3 signaling	12	16	1	0	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2990846	SUMOylation	94	123	7	5	2	4	4	4	7	1	1	28	122	4741	0.83556	0.52318	0.52318	0.81	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-3108232	SUMO E3 ligases SUMOylate target proteins	89	117	7	5	2	4	4	4	7	1	1	28	116	4747	0.84809	0.50542	0.50542	0.85	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand	22	28	1	1	1	1	1	1	1	1	1	28	27	4836	0.98834	0.15375	0.15375	3.57	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-383280	Nuclear Receptor transcription pathway	29	37	3	2	0	3	3	3	3	0	0	29	37	4826	0.80187	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4090294	SUMOylation of intracellular receptors	15	22	1	0	0	0	0	0	1	0	0	29	22	4841	0.87714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5625740	RHO GTPases activate PKNs	30	47	2	2	1	1	1	1	2	0	0	29	47	4816	0.7552	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	14	31	1	1	1	0	0	0	1	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-177929	Signaling by EGFR	24	27	4	4	1	4	4	4	4	1	1	28	26	4837	0.98913	0.14868	0.14868	3.7	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-179812	GRB2 events in EGFR signaling	7	8	1	1	1	1	1	1	1	1	1	28	7	4856	0.99907	0.046485	0.046485	12.5	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-180292	GAB1 signalosome	10	12	2	2	0	2	2	2	2	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-180336	SHC1 events in EGFR signaling	8	9	1	1	1	1	1	1	1	1	1	28	8	4855	0.99881	0.052146	0.052146	11.11	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-182971	EGFR downregulation	16	18	1	1	0	1	1	1	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856825	Cargo recognition for clathrin-mediated endocytosis	47	58	4	4	0	4	4	4	4	0	0	29	58	4805	0.70689	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8876725	Protein methylation	8	12	1	1	0	1	1	1	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-354192	Integrin signaling	13	15	2	2	0	2	2	2	2	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-372708	p130Cas linkage to MAPK signaling for integrins	7	8	1	1	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5674135	MAP2K and MAPK activation	23	24	3	3	1	3	3	3	3	1	1	28	23	4840	0.99136	0.13328	0.13328	4.17	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-76009	Platelet Aggregation (Plug Formation)	15	21	2	2	0	2	2	2	2	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8875878	MET promotes cell motility	23	24	2	2	0	2	2	2	2	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5578775	Ion homeostasis	22	27	1	1	0	1	1	1	1	0	0	29	27	4836	0.85132	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-936837	Ion transport by P-type ATPases	18	20	1	1	0	1	1	1	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72165	mRNA Splicing - Minor Pathway	41	43	6	3	3	2	2	2	6	1	1	28	42	4821	0.97363	0.22646	0.22646	2.33	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-72172	mRNA Splicing	122	127	11	5	4	6	6	5	11	2	2	27	125	4738	0.9618	0.17289	0.17289	1.57	445170;394059	polr2eb;cdc5l	ENSDARG00000026183;ENSDARG00000043797		44.637150000000005	44.637150000000005	38.4902	8.693100057229254	44.99364643375796	8.678468136165248	25.6738	25.6738	23.5524	3.000112651218292	25.796831997100046	2.995062966847137	77.8443	77.8443	62.902	21.131603313047542	78.71088857842369	21.096035339643706					50.7841;38.4902	27.7952;23.5524	92.7866;62.902	2	0	2	445170;394059	ENSDARG00000026183;ENSDARG00000043797	44.637150000000005	44.637150000000005	8.693100057229254	25.6738	25.6738	3.000112651218292	77.8443	77.8443	21.131603313047542	50.7841;38.4902	27.7952;23.5524	92.7866;62.902	0															0						Linear,2(1)	2.4369190933573504	4.969471335411072	1.9996205568313599	2.969850778579712	0.6860563691103875	2.484735667705536	32.58912800000001	56.685172	21.515856	29.831744	48.55739199999999	107.13120800000002	UP	1.0	0.0	0.0	
R-DRE-5358351	Signaling by Hedgehog	68	81	4	2	1	3	3	3	4	0	0	29	81	4782	0.61533	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5632684	Hedgehog 'on' state	47	53	4	2	1	3	3	3	4	0	0	29	53	4810	0.72847	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-181429	Serotonin Neurotransmitter Release Cycle	9	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-181430	Norepinephrine Neurotransmitter Release Cycle	8	10	1	1	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-210500	Glutamate Neurotransmitter Release Cycle	13	18	1	1	0	1	1	1	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-264642	Acetylcholine Neurotransmitter Release Cycle	10	11	2	2	0	2	2	2	2	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8849932	Synaptic adhesion-like molecules	8	13	1	0	0	1	1	1	1	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-422085	Synthesis, secretion, and deacylation of Ghrelin	7	11	2	2	2	1	1	0	2	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-200425	Carnitine metabolism	9	10	1	0	0	0	0	0	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-170834	Signaling by TGF-beta Receptor Complex	32	39	4	3	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	5	5	1	1	0	1	1	1	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73614	Pyrimidine salvage	5	5	1	0	0	1	1	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013424	RHOV GTPase cycle	18	21	1	1	1	1	1	1	1	1	1	28	20	4843	0.99335	0.11761	0.11761	4.76	100005849	rhov	ENSDARG00000070434		89.3983	89.3983	89.3983		89.3983		33.4223	33.4223	33.4223		33.4223		239.123	239.123	239.123		239.12299999999996						89.3983	33.4223	239.123	0	1	0															1	100005849	ENSDARG00000070434	89.3983	89.3983		33.4223	33.4223		239.123	239.123		89.3983	33.4223	239.123	0						Linear,1(1)	5.496060371398926	5.496060371398926	5.496060371398926	5.496060371398926	0.0	5.496060371398926	89.3983	89.3983	33.4223	33.4223	239.123	239.123	DOWN	0.0	1.0	0.0	
R-DRE-5654687	Downstream signaling of activated FGFR1	12	23	2	2	1	2	2	2	2	1	1	28	22	4841	0.99205	0.12808	0.12808	4.35	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654688	SHC-mediated cascade:FGFR1	7	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654689	PI-3K cascade:FGFR1	6	16	1	1	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654693	FRS-mediated FGFR1 signaling	6	16	1	1	1	1	1	1	1	1	1	28	15	4848	0.99613	0.090879	0.090879	6.25	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654695	PI-3K cascade:FGFR2	5	16	1	1	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654696	Downstream signaling of activated FGFR2	8	20	2	2	1	2	2	2	2	1	1	28	19	4844	0.99397	0.11232	0.11232	5.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654699	SHC-mediated cascade:FGFR2	6	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654700	FRS-mediated FGFR2 signaling	5	16	1	1	1	1	1	1	1	1	1	28	15	4848	0.99613	0.090879	0.090879	6.25	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654726	Negative regulation of FGFR1 signaling	16	25	1	0	0	0	0	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654727	Negative regulation of FGFR2 signaling	15	25	1	0	0	0	0	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654736	Signaling by FGFR1	26	37	3	2	1	2	2	2	3	1	1	28	36	4827	0.98012	0.19813	0.19813	2.7	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654738	Signaling by FGFR2	40	54	7	4	3	4	4	4	7	2	2	27	52	4811	0.99621	0.040152	0.040152	3.7	553656;445170	hrasb;polr2eb	ENSDARG00000005651;ENSDARG00000026183		46.271550000000005	46.271550000000005	41.759	6.3817094108866455	47.31308732071834	6.209397315690282	26.2678	26.2678	24.7404	2.160069795168673	26.620337723385934	2.1017458997651888	81.63560000000001	81.63560000000001	70.4846	15.769895434022395	84.20935157357374	15.344093576195828					41.759;50.7841	24.7404;27.7952	70.4846;92.7866	2	0	2	553656;445170	ENSDARG00000005651;ENSDARG00000026183	46.271550000000005	46.271550000000005	6.3817094108866455	26.2678	26.2678	2.160069795168673	81.63560000000001	81.63560000000001	15.769895434022395	41.759;50.7841	24.7404;27.7952	70.4846;92.7866	0															0						Linear,2(1)	2.8881210285308203	6.171033501625061	1.9996205568313599	4.171412944793701	1.5356891248574969	3.0855167508125305	37.426952	55.11614800000001	23.274096	29.261504000000002	59.77964	103.49156000000002	UP	1.0	0.0	0.0	
R-DRE-72163	mRNA Splicing - Major Pathway	116	120	10	5	4	6	6	5	10	2	2	27	118	4745	0.96692	0.15815	0.15815	1.67	445170;394059	polr2eb;cdc5l	ENSDARG00000026183;ENSDARG00000043797		44.637150000000005	44.637150000000005	38.4902	8.693100057229254	44.99364643375796	8.678468136165248	25.6738	25.6738	23.5524	3.000112651218292	25.796831997100046	2.995062966847137	77.8443	77.8443	62.902	21.131603313047542	78.71088857842369	21.096035339643706					50.7841;38.4902	27.7952;23.5524	92.7866;62.902	2	0	2	445170;394059	ENSDARG00000026183;ENSDARG00000043797	44.637150000000005	44.637150000000005	8.693100057229254	25.6738	25.6738	3.000112651218292	77.8443	77.8443	21.131603313047542	50.7841;38.4902	27.7952;23.5524	92.7866;62.902	0															0						Linear,2(1)	2.4369190933573504	4.969471335411072	1.9996205568313599	2.969850778579712	0.6860563691103875	2.484735667705536	32.58912800000001	56.685172	21.515856	29.831744	48.55739199999999	107.13120800000002	UP	1.0	0.0	0.0	
R-DRE-75105	Fatty acyl-CoA biosynthesis	19	21	2	2	1	1	1	1	2	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-75876	Synthesis of very long-chain fatty acyl-CoAs	15	15	2	2	1	1	1	1	2	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193704	p75 NTR receptor-mediated signalling	30	47	2	2	2	0	0	0	2	0	0	29	47	4816	0.7552	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4086400	PCP/CE pathway	57	66	4	2	1	3	3	3	4	0	0	29	66	4797	0.67364	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416482	G alpha (12/13) signalling events	33	45	2	2	1	1	1	1	2	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416572	Sema4D induced cell migration and growth-cone collapse	6	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5625900	RHO GTPases activate CIT	4	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5627117	RHO GTPases Activate ROCKs	3	3	1	1	0	1	1	1	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5689896	Ovarian tumor domain proteases	14	19	1	1	1	0	0	0	1	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1852241	Organelle biogenesis and maintenance	99	121	8	6	5	6	6	5	8	4	4	25	117	4746	0.99937	0.0052415	0.0052415	3.31	436914;436878;436667;394141	acss2;sirt5;b9d2;dctn2	ENSDARG00000037781;ENSDARG00000039684;ENSDARG00000017385;ENSDARG00000031388		50.09417499999999	43.1083	30.7771	23.327977516903765	43.19336253751742	15.717655217004223	25.907	25.158549999999998	20.0664	5.645607157782054	24.51343181072352	4.254314707565784	101.104675	74.03745	47.2048	73.82616619209276	77.99465694806723	47.85763113294867					37.9274;83.383;48.2892;30.7771	23.3493;33.2445;26.9678;20.0664	61.6071;209.139;86.4678;47.2048	3	1	3	436914;436878;436667	ENSDARG00000037781;ENSDARG00000039684;ENSDARG00000017385	56.5332	48.2892	23.82279464798367	27.853866666666665	26.9678	5.0067535752554875	119.07130000000001	86.4678	78.98516657316108	37.9274;83.383;48.2892	23.3493;33.2445;26.9678	61.6071;209.139;86.4678	1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,4(1)	2.953553305818079	13.259923458099365	1.7204608917236328	6.103963375091553	1.9419754498969377	2.71774959564209	27.232757033434325	72.95559296656566	20.374304985373588	31.43969501462642	28.755032131749104	173.45431786825094	UP	0.75	0.25	0.0	
R-DRE-2565942	Regulation of PLK1 Activity at G2/M Transition	37	46	3	2	1	2	2	2	3	1	1	28	45	4818	0.9701	0.24025	0.24025	2.17	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-3108214	SUMOylation of DNA damage response and repair proteins	41	52	5	3	2	2	2	2	5	1	1	28	51	4812	0.96252	0.26714	0.26714	1.92	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-380259	Loss of Nlp from mitotic centrosomes	33	41	3	2	1	2	2	2	3	1	1	28	40	4823	0.97588	0.21712	0.21712	2.44	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-380270	Recruitment of mitotic centrosome proteins and complexes	37	45	3	2	1	2	2	2	3	1	1	28	44	4819	0.9713	0.23568	0.23568	2.22	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-380284	Loss of proteins required for interphase microtubule organization from the centrosome	33	41	3	2	1	2	2	2	3	1	1	28	40	4823	0.97588	0.21712	0.21712	2.44	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-380287	Centrosome maturation	37	45	3	2	1	2	2	2	3	1	1	28	44	4819	0.9713	0.23568	0.23568	2.22	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-380320	Recruitment of NuMA to mitotic centrosomes	37	45	3	2	1	2	2	2	3	1	1	28	44	4819	0.9713	0.23568	0.23568	2.22	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-453274	Mitotic G2-G2/M phases	96	110	9	4	2	6	6	6	9	1	1	28	109	4754	0.86242	0.48389	0.48389	0.91	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-5617833	Cilium Assembly	77	99	6	4	3	4	4	3	6	2	2	27	97	4766	0.97993	0.11577	0.11577	2.02	436667;394141	b9d2;dctn2	ENSDARG00000017385;ENSDARG00000031388		39.53315	39.53315	30.7771	12.382924662816947	40.733577228320584	12.266000658079715	23.5171	23.5171	20.0664	4.880026739680849	23.99018024015005	4.83394778134383	66.8363	66.8363	47.2048	27.763133549727428	69.52771760642932	27.500984110311535					48.2892;30.7771	26.9678;20.0664	86.4678;47.2048	1	1	1	436667	ENSDARG00000017385	48.2892	48.2892		26.9678	26.9678		86.4678	86.4678		48.2892	26.9678	86.4678	1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,2(1)	2.6919145185341424	5.43549919128418	2.3439059257507324	3.0915932655334473	0.528694788167688	2.71774959564209	22.371292	56.695008	16.753728000000002	30.280471999999996	28.358559999999997	105.31403999999999	CONFLICT	0.5	0.5	0.0	
R-DRE-5620912	Anchoring of the basal body to the plasma membrane	43	55	4	3	2	3	3	3	4	2	2	27	53	4810	0.996	0.041517	0.041517	3.64	436667;394141	b9d2;dctn2	ENSDARG00000017385;ENSDARG00000031388		39.53315	39.53315	30.7771	12.382924662816947	40.733577228320584	12.266000658079715	23.5171	23.5171	20.0664	4.880026739680849	23.99018024015005	4.83394778134383	66.8363	66.8363	47.2048	27.763133549727428	69.52771760642932	27.500984110311535					48.2892;30.7771	26.9678;20.0664	86.4678;47.2048	1	1	1	436667	ENSDARG00000017385	48.2892	48.2892		26.9678	26.9678		86.4678	86.4678		48.2892	26.9678	86.4678	1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,2(1)	2.6919145185341424	5.43549919128418	2.3439059257507324	3.0915932655334473	0.528694788167688	2.71774959564209	22.371292	56.695008	16.753728000000002	30.280471999999996	28.358559999999997	105.31403999999999	CONFLICT	0.5	0.5	0.0	
R-DRE-5696394	DNA Damage Recognition in GG-NER	22	23	1	1	0	1	1	1	1	0	0	29	23	4840	0.87192	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69275	G2/M Transition	95	109	9	4	2	6	6	6	9	1	1	28	108	4755	0.86444	0.48075	0.48075	0.92	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-8854518	AURKA Activation by TPX2	34	42	3	2	1	2	2	2	3	1	1	28	41	4822	0.97476	0.2218	0.2218	2.38	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-9646399	Aggrephagy	20	24	1	0	0	1	1	0	1	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-449836	Other interleukin signaling	7	12	1	1	0	1	1	1	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-194002	Glucocorticoid biosynthesis	5	9	1	0	0	1	1	1	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196071	Metabolism of steroid hormones	13	21	1	0	0	1	1	1	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	4	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-195253	Degradation of beta-catenin by the destruction complex	54	57	5	2	1	3	3	3	5	0	0	29	57	4806	0.71116	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201681	TCF dependent signaling in response to WNT	93	127	6	3	2	4	4	4	6	0	0	29	127	4736	0.46532	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201722	Formation of the beta-catenin:TCF transactivating complex	28	44	1	1	1	0	0	0	1	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018519	Estrogen-dependent gene expression	53	74	6	4	3	3	3	3	6	1	1	28	73	4790	0.9295	0.35809	0.35809	1.35	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6811434	COPI-dependent Golgi-to-ER retrograde traffic	50	57	3	1	0	2	2	2	3	0	0	29	57	4806	0.71116	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856688	Golgi-to-ER retrograde transport	54	64	3	1	0	2	2	2	3	0	0	29	64	4799	0.68181	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983189	Kinesins	25	31	3	1	0	2	2	2	3	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-877300	Interferon gamma signaling	8	11	1	1	1	0	0	0	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-877312	Regulation of IFNG signaling	4	7	1	1	1	0	0	0	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-913531	Interferon Signaling	17	24	1	1	1	0	0	0	1	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3065679	SUMO is proteolytically processed	6	6	1	0	0	0	0	0	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3215018	Processing and activation of SUMO	9	10	1	0	0	0	0	0	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73884	Base Excision Repair	26	38	3	2	1	2	2	2	3	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73929	Base-Excision Repair, AP Site Formation	12	24	1	1	1	0	0	0	1	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73933	Resolution of Abasic Sites (AP sites)	17	19	2	1	0	2	2	2	2	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-430039	mRNA decay by 5' to 3' exoribonuclease	10	10	1	1	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-400206	Regulation of lipid metabolism by PPARalpha	11	13	2	2	1	2	2	2	2	1	1	28	12	4851	0.99746	0.07447	0.07447	7.69	554095	fabp1b.1	ENSDARG00000059227		60.5176	60.5176	60.5176		60.5176		30.1468	30.1468	30.1468		30.1468		121.485	121.485	121.485		121.485		0.0	60.5176			60.5176	30.1468	121.485	1	0	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	0															0						Linear,1(1)	1.5967966318130493	1.5967966318130493	1.5967966318130493	1.5967966318130493	0.0	1.5967966318130493	60.5176	60.5176	30.1468	30.1468	121.485	121.485	UP	1.0	0.0	0.0	
R-DRE-174824	Plasma lipoprotein assembly, remodeling, and clearance	29	33	1	0	0	1	1	0	1	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8964038	LDL clearance	9	12	1	0	0	1	1	0	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8964043	Plasma lipoprotein clearance	15	18	1	0	0	1	1	0	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211897	Cytochrome P450 - arranged by substrate type	31	37	3	3	1	3	3	2	3	0	0	29	37	4826	0.80187	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211935	Fatty acids	9	11	1	1	1	1	1	0	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211958	Miscellaneous substrates	12	15	1	1	1	1	1	0	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211981	Xenobiotics	15	17	1	1	1	1	1	0	1	0	0	29	17	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211999	CYP2E1 reactions	8	10	1	1	1	1	1	0	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018677	Biosynthesis of DHA-derived SPMs	12	16	1	1	1	1	1	0	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018678	Biosynthesis of specialized proresolving mediators (SPMs)	12	17	1	1	1	1	1	0	1	0	0	29	17	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018682	Biosynthesis of maresins	10	12	1	1	1	1	1	0	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9027307	Biosynthesis of maresin-like SPMs	10	12	1	1	1	1	1	0	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-432047	Passive transport by Aquaporins	7	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-445717	Aquaporin-mediated transport	27	31	1	1	1	0	0	0	1	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2187338	Visual phototransduction	42	47	5	4	4	2	2	1	5	1	1	28	46	4817	0.96889	0.2448	0.2448	2.13	570333	rcvrna	ENSDARG00000052223		57.3841	57.3841	57.3841		57.3841		29.4448	29.4448	29.4448		29.444800000000004		111.834	111.834	111.834		111.834						57.3841	29.4448	111.834	1	0	1	570333	ENSDARG00000052223	57.3841	57.3841		29.4448	29.4448		111.834	111.834		57.3841	29.4448	111.834	0															0						Linear,1(1)	2.16167950630188	2.16167950630188	2.16167950630188	2.16167950630188	0.0	2.16167950630188	57.3841	57.3841	29.4448	29.4448	111.834	111.834	UP	1.0	0.0	0.0	
R-DRE-9709957	Sensory Perception	48	71	5	4	4	2	2	1	5	1	1	28	70	4793	0.93443	0.34636	0.34636	1.41	570333	rcvrna	ENSDARG00000052223		57.3841	57.3841	57.3841		57.3841		29.4448	29.4448	29.4448		29.444800000000004		111.834	111.834	111.834		111.834						57.3841	29.4448	111.834	1	0	1	570333	ENSDARG00000052223	57.3841	57.3841		29.4448	29.4448		111.834	111.834		57.3841	29.4448	111.834	0															0						Linear,1(1)	2.16167950630188	2.16167950630188	2.16167950630188	2.16167950630188	0.0	2.16167950630188	57.3841	57.3841	29.4448	29.4448	111.834	111.834	UP	1.0	0.0	0.0	
R-DRE-975634	Retinoid metabolism and transport	13	15	2	1	1	1	1	0	2	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-202403	TCR signaling	15	19	3	2	1	2	2	1	3	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-202427	Phosphorylation of CD3 and TCR zeta chains	2	2	1	1	0	1	1	1	1	0	0	29	2	4861	0.98818	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559580	Oxidative Stress Induced Senescence	42	59	1	1	1	0	0	0	1	0	0	29	59	4804	0.70265	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559582	Senescence-Associated Secretory Phenotype (SASP)	35	53	2	2	2	1	1	1	2	1	1	28	52	4811	0.96119	0.27153	0.27153	1.89	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-8934593	Regulation of RUNX1 Expression and Activity	4	12	1	1	1	0	0	0	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5675221	Negative regulation of MAPK pathway	30	31	3	2	1	2	2	2	3	1	1	28	30	4833	0.98581	0.1688	0.1688	3.23	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-75955	RNA Polymerase II Transcription Elongation	34	34	6	2	2	4	4	3	6	1	1	28	33	4830	0.98307	0.18359	0.18359	2.94	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-8866654	E3 ubiquitin ligases ubiquitinate target proteins	27	30	2	1	1	2	2	1	2	1	1	28	29	4834	0.98668	0.16381	0.16381	3.33	559933	pex14	ENSDARG00000028322		58.814	58.814	58.814		58.814		29.9372	29.9372	29.9372		29.9372		115.545	115.545	115.545		115.545						58.814	29.9372	115.545	1	0	1	559933	ENSDARG00000028322	58.814	58.814		29.9372	29.9372		115.545	115.545		58.814	29.9372	115.545	0															0						Linear,1(1)	2.1846325397491455	2.1846325397491455	2.1846325397491455	2.1846325397491455	0.0	2.1846325397491455	58.814	58.814	29.9372	29.9372	115.545	115.545	UP	1.0	0.0	0.0	
R-DRE-428157	Sphingolipid metabolism	32	50	1	1	0	1	1	1	1	0	0	29	50	4813	0.74172	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1268020	Mitochondrial protein import	12	15	1	0	0	1	1	1	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2299718	Condensation of Prophase Chromosomes	20	36	1	1	1	0	0	0	1	0	0	29	36	4827	0.80669	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68875	Mitotic Prophase	47	64	4	3	2	1	1	1	4	1	1	28	63	4800	0.94544	0.31819	0.31819	1.56	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-211000	Gene Silencing by RNA	45	63	6	3	3	3	3	3	6	2	2	27	61	4802	0.99414	0.053042	0.053042	3.17	445170;337461	polr2eb;nup35	ENSDARG00000026183;ENSDARG00000012222		67.526	67.526	50.7841	23.676622039894124	57.96138294346949	19.432411902382363	30.4947	30.4947	27.7952	3.8176695116261814	28.952480553933295	3.133323931601647	153.35580000000002	153.35580000000002	92.7866	85.65778410208843	118.7527260704933	70.3029908790387					50.7841;84.2679	27.7952;33.1942	92.7866;213.925	1	1	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,2(1)	5.153522436563855	15.281537175178528	1.9996205568313599	13.281916618347168	7.977788052452105	7.640768587589264	34.711876000000004	100.34012399999999	25.203680000000002	35.785720000000005	34.64016800000003	272.071432	CONFLICT	0.5	0.5	0.0	
R-DRE-212165	Epigenetic regulation of gene expression	42	61	4	3	3	2	2	1	4	1	1	28	60	4803	0.94994	0.30576	0.30576	1.64	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-212300	PRC2 methylates histones and DNA	21	39	2	1	1	1	1	0	2	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3214858	RMTs methylate histone arginines	20	37	2	2	2	0	0	0	2	0	0	29	37	4826	0.80187	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-427359	SIRT1 negatively regulates rRNA expression	14	30	1	1	1	0	0	0	1	0	0	29	30	4833	0.83619	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5250913	Positive epigenetic regulation of rRNA expression	32	49	3	3	3	1	1	1	3	1	1	28	48	4815	0.9664	0.25382	0.25382	2.04	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-5250924	B-WICH complex positively regulates rRNA expression	32	49	3	3	3	1	1	1	3	1	1	28	48	4815	0.9664	0.25382	0.25382	2.04	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-5250941	Negative epigenetic regulation of rRNA expression	14	30	1	1	1	0	0	0	1	0	0	29	30	4833	0.83619	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5578749	Transcriptional regulation by small RNAs	40	57	6	3	3	3	3	3	6	2	2	27	55	4808	0.99558	0.044298	0.044298	3.51	445170;337461	polr2eb;nup35	ENSDARG00000026183;ENSDARG00000012222		67.526	67.526	50.7841	23.676622039894124	57.96138294346949	19.432411902382363	30.4947	30.4947	27.7952	3.8176695116261814	28.952480553933295	3.133323931601647	153.35580000000002	153.35580000000002	92.7866	85.65778410208843	118.7527260704933	70.3029908790387					50.7841;84.2679	27.7952;33.1942	92.7866;213.925	1	1	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,2(1)	5.153522436563855	15.281537175178528	1.9996205568313599	13.281916618347168	7.977788052452105	7.640768587589264	34.711876000000004	100.34012399999999	25.203680000000002	35.785720000000005	34.64016800000003	272.071432	CONFLICT	0.5	0.5	0.0	
R-DRE-73728	RNA Polymerase I Promoter Opening	15	31	1	1	1	0	0	0	1	0	0	29	31	4832	0.8312	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73772	RNA Polymerase I Promoter Escape	35	51	2	2	2	1	1	1	2	1	1	28	50	4813	0.96383	0.26273	0.26273	1.96	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-73854	RNA Polymerase I Promoter Clearance	44	60	2	2	2	1	1	1	2	1	1	28	59	4804	0.9514	0.30157	0.30157	1.67	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-73864	RNA Polymerase I Transcription	45	61	2	2	2	1	1	1	2	1	1	28	60	4803	0.94994	0.30576	0.30576	1.64	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	26	44	1	1	1	0	0	0	1	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	23	29	3	2	1	2	2	2	3	0	0	29	29	4834	0.8412	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	14	19	1	0	0	1	1	1	1	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9609523	Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	11	12	3	2	1	3	3	1	3	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	18	20	1	0	0	1	1	1	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5656169	Termination of translesion DNA synthesis	14	15	1	0	0	1	1	1	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73893	DNA Damage Bypass	22	25	1	0	0	1	1	1	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110330	Recognition and association of DNA glycosylase with site containing an affected purine	9	20	1	1	1	0	0	0	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110331	Cleavage of the damaged purine	10	21	1	1	1	0	0	0	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-606279	Deposition of new CENPA-containing nucleosomes at the centromere	23	33	2	2	2	0	0	0	2	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73927	Depurination	10	21	1	1	1	0	0	0	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-774815	Nucleosome assembly	23	33	2	2	2	0	0	0	2	0	0	29	33	4830	0.82131	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9670095	Inhibition of DNA recombination at telomere	11	21	1	1	1	0	0	0	1	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4551638	SUMOylation of chromatin organization proteins	28	30	3	1	1	1	1	1	3	1	1	28	29	4834	0.98668	0.16381	0.16381	3.33	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-69273	Cyclin A/B1/B2 associated events during G2/M transition	15	16	2	0	0	1	1	1	2	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	10	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2046106	alpha-linolenic acid (ALA) metabolism	10	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70326	Glucose metabolism	32	34	1	1	0	0	0	0	1	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5368287	Mitochondrial translation	53	55	3	2	0	3	3	2	3	0	0	29	55	4808	0.71976	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5389840	Mitochondrial translation elongation	52	53	3	2	0	3	3	2	3	0	0	29	53	4810	0.72847	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5419276	Mitochondrial translation termination	52	54	3	2	0	3	3	2	3	0	0	29	54	4809	0.7241	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2995410	Nuclear Envelope (NE) Reassembly	35	35	3	2	2	3	3	3	3	2	2	27	33	4830	0.99892	0.01789	0.01789	5.71	406457;337461	rcc1;nup35	ENSDARG00000037158;ENSDARG00000012222		73.82554999999999	73.82554999999999	63.3832	14.767712993046755	72.56425885613756	14.659591957003137	31.998350000000002	31.998350000000002	30.8025	1.6911872885637713	31.853907895072673	1.6788053495410975	172.1755	172.1755	130.426	59.04270912229562	167.13273906872638	58.61043102452036	0.5	73.82554999999999			63.3832;84.2679	30.8025;33.1942	130.426;213.925	0	2	0															2	406457;337461	ENSDARG00000037158;ENSDARG00000012222	73.82554999999999	73.82554999999999	14.767712993046755	31.998350000000002	31.998350000000002	1.6911872885637713	172.1755	172.1755	59.04270912229562	63.3832;84.2679	30.8025;33.1942	130.426;213.925	0						Linear,2(1)	6.649100319268211	16.61054277420044	3.3286261558532715	13.281916618347168	7.038039181148822	8.30527138710022	53.358543999999995	94.29255599999999	29.654484	34.34221600000001	90.34647999999999	254.00452	DOWN	0.0	1.0	0.0	
R-DRE-9615933	Postmitotic nuclear pore complex (NPC) reformation	15	15	2	2	2	2	2	2	2	2	2	27	13	4850	0.99992	0.0033969	0.0033969	13.33	406457;337461	rcc1;nup35	ENSDARG00000037158;ENSDARG00000012222		73.82554999999999	73.82554999999999	63.3832	14.767712993046755	72.56425885613756	14.659591957003137	31.998350000000002	31.998350000000002	30.8025	1.6911872885637713	31.853907895072673	1.6788053495410975	172.1755	172.1755	130.426	59.04270912229562	167.13273906872638	58.61043102452036	0.0	63.3832	0.5	73.82554999999999	63.3832;84.2679	30.8025;33.1942	130.426;213.925	0	2	0															2	406457;337461	ENSDARG00000037158;ENSDARG00000012222	73.82554999999999	73.82554999999999	14.767712993046755	31.998350000000002	31.998350000000002	1.6911872885637713	172.1755	172.1755	59.04270912229562	63.3832;84.2679	30.8025;33.1942	130.426;213.925	0						Linear,2(1)	6.649100319268211	16.61054277420044	3.3286261558532715	13.281916618347168	7.038039181148822	8.30527138710022	53.358543999999995	94.29255599999999	29.654484	34.34221600000001	90.34647999999999	254.00452	DOWN	0.0	1.0	0.0	
R-DRE-8873719	RAB geranylgeranylation	32	40	2	2	2	1	1	1	2	1	1	28	39	4824	0.97697	0.21241	0.21241	2.5	403031	rab4a	ENSDARG00000019144		0.201926	0.201926	0.201926		0.201926		0.0364948	0.0364948	0.0364948		0.0364948		1.11725	1.11725	1.11725		1.11725						0.201926	0.0364948	1.11725	0	1	0															1	403031	ENSDARG00000019144	0.201926	0.201926		0.0364948	0.0364948		1.11725	1.11725		0.201926	0.0364948	1.11725	0						Hill,1(1)	Infinity	Infinity	Infinity	Infinity	0.0	Infinity	0.201926	0.201926	0.0364948	0.0364948	1.11725	1.11725	DOWN	0.0	1.0	0.0	
R-DRE-416700	Other semaphorin interactions	2	5	1	1	0	1	1	1	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	38	41	4	2	1	3	3	3	4	0	0	29	41	4822	0.78288	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211976	Endogenous sterols	13	16	2	2	0	2	2	2	2	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3371511	HSF1 activation	9	9	1	1	0	1	1	1	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1614517	Sulfide oxidation to sulfate	2	2	1	0	0	0	0	0	1	0	0	29	2	4861	0.98818	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1614558	Degradation of cysteine and homocysteine	4	4	1	0	0	0	0	0	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-162710	Synthesis of glycosylphosphatidylinositol (GPI)	12	14	1	0	0	1	1	1	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163125	Post-translational modification: synthesis of GPI-anchored proteins	14	16	1	0	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1482788	Acyl chain remodelling of PC	8	15	1	0	0	1	1	0	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1482925	Acyl chain remodelling of PG	5	8	1	0	0	1	1	0	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1483166	Synthesis of PA	18	24	1	0	0	1	1	0	1	0	0	29	24	4839	0.86672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-140837	Intrinsic Pathway of Fibrin Clot Formation	13	17	1	0	0	1	1	1	1	0	0	29	17	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-140875	Common Pathway of Fibrin Clot Formation	7	8	1	0	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-140877	Formation of Fibrin Clot (Clotting Cascade)	14	18	1	0	0	1	1	1	1	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8956319	Nucleobase catabolism	17	20	1	1	1	1	1	1	1	1	1	28	19	4844	0.99397	0.11232	0.11232	5.0	561810	dnph1	ENSDARG00000075730		92.0486	92.0486	92.0486		92.0486		33.5239	33.5239	33.5239		33.5239		252.744	252.744	252.744		252.74399999999997		0.0	92.0486			92.0486	33.5239	252.744	0	1	0															1	561810	ENSDARG00000075730	92.0486	92.0486		33.5239	33.5239		252.744	252.744		92.0486	33.5239	252.744	0						Linear,1(1)	2.877150297164917	2.877150297164917	2.877150297164917	2.877150297164917	0.0	2.877150297164917	92.0486	92.0486	33.5239	33.5239	252.744	252.744	DOWN	0.0	1.0	0.0	
R-DRE-71384	Ethanol oxidation	5	6	2	2	1	2	2	2	2	1	1	28	5	4858	0.9995	0.035063	0.035063	16.67	436914	acss2	ENSDARG00000037781		37.9274	37.9274	37.9274		37.9274		23.3493	23.3493	23.3493		23.3493		61.6071	61.6071	61.6071		61.6071		0.0	37.9274	0.0	37.9274	37.9274	23.3493	61.6071	1	0	1	436914	ENSDARG00000037781	37.9274	37.9274		23.3493	23.3493		61.6071	61.6071		37.9274	23.3493	61.6071	0															0						Linear,1(1)	1.7204608917236328	1.7204608917236328	1.7204608917236328	1.7204608917236328	0.0	1.7204608917236328	37.9274	37.9274	23.3493	23.3493	61.6071	61.6071	UP	1.0	0.0	0.0	
R-DRE-171306	Packaging Of Telomere Ends	9	19	1	1	1	0	0	0	1	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5689603	UCH proteinases	51	61	4	2	1	3	3	3	4	0	0	29	61	4802	0.69424	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3238698	WNT ligand biogenesis and trafficking	12	20	1	1	1	0	0	0	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4641258	Degradation of DVL	37	42	4	2	1	3	3	3	4	0	0	29	42	4821	0.7782	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-173736	Alternative complement activation	2	2	1	1	1	1	1	1	1	1	1	28	1	4862	0.99997	0.011822	0.011822	50.0	553553	cfd	ENSDARG00000039579		58.5336	58.5336	58.5336		58.5336		29.7061	29.7061	29.7061		29.7061		115.336	115.336	115.336		115.33599999999998		0.0	58.5336	0.0	58.5336	58.5336	29.7061	115.336	0	1	0															1	553553	ENSDARG00000039579	58.5336	58.5336		29.7061	29.7061		115.336	115.336		58.5336	29.7061	115.336	0						Linear,1(1)	1.672296166419983	1.672296166419983	1.672296166419983	1.672296166419983	0.0	1.672296166419983	58.5336	58.5336	29.7061	29.7061	115.336	115.336	DOWN	0.0	1.0	0.0	
R-DRE-5173214	O-glycosylation of TSR domain-containing proteins	9	16	1	1	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-113418	Formation of the Early Elongation Complex	22	22	4	2	2	2	2	2	4	1	1	28	21	4842	0.99272	0.12286	0.12286	4.55	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6781823	Formation of TC-NER Pre-Incision Complex	37	38	3	1	1	2	2	2	3	1	1	28	37	4826	0.97909	0.20292	0.20292	2.63	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	42	44	4	1	1	3	3	3	4	1	1	28	43	4820	0.97247	0.23108	0.23108	2.27	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6796648	TP53 Regulates Transcription of DNA Repair Genes	28	28	5	2	2	3	3	2	5	1	1	28	27	4836	0.98834	0.15375	0.15375	3.57	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6803529	FGFR2 alternative splicing	19	20	4	2	2	2	2	2	4	1	1	28	19	4844	0.99397	0.11232	0.11232	5.0	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866		0.0	50.7841			50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-6807505	RNA polymerase II transcribes snRNA genes	42	51	5	2	2	3	3	2	5	1	1	28	50	4813	0.96383	0.26273	0.26273	1.96	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-72086	mRNA Capping	22	22	4	2	2	2	2	2	4	1	1	28	21	4842	0.99272	0.12286	0.12286	4.55	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-77075	RNA Pol II CTD phosphorylation and interaction with CE	22	22	4	2	2	2	2	2	4	1	1	28	21	4842	0.99272	0.12286	0.12286	4.55	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	14	17	2	1	1	1	1	0	2	0	0	29	17	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	38	41	4	2	1	3	3	3	4	0	0	29	41	4822	0.78288	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9639288	Amino acids regulate mTORC1	31	36	1	1	1	0	0	0	1	0	0	29	36	4827	0.80669	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9711097	Cellular response to starvation	31	36	1	1	1	0	0	0	1	0	0	29	36	4827	0.80669	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	7	8	1	1	1	1	1	0	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-400508	Incretin synthesis, secretion, and inactivation	7	8	1	1	1	1	1	0	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3232142	SUMOylation of ubiquitinylation proteins	20	27	3	2	2	1	1	1	3	1	1	28	26	4837	0.98913	0.14868	0.14868	3.7	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-8948747	Regulation of PTEN localization	5	11	1	1	1	0	0	0	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6807004	Negative regulation of MET activity	10	12	1	1	1	0	0	0	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8851805	MET activates RAS signaling	7	8	1	1	1	1	1	1	1	1	1	28	7	4856	0.99907	0.046485	0.046485	12.5	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-8851907	MET activates PI3K/AKT signaling	4	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8875555	MET activates RAP1 and RAC1	9	10	2	2	0	2	2	2	2	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3899300	SUMOylation of transcription cofactors	29	34	2	1	0	1	1	1	2	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193648	NRAGE signals death through JNK	17	25	1	1	1	0	0	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-204998	Cell death signalling via NRAGE, NRIF and NADE	25	34	2	2	2	0	0	0	2	0	0	29	34	4829	0.81641	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-156590	Glutathione conjugation	18	19	3	2	1	3	3	2	3	0	0	29	19	4844	0.89299	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174403	Glutathione synthesis and recycling	7	8	1	0	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	16	26	2	2	0	2	2	2	2	0	0	29	26	4837	0.85643	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-187577	SCF(Skp2)-mediated degradation of p27/p21	41	44	4	2	1	3	3	3	4	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69563	p53-Dependent G1 DNA Damage Response	40	44	4	2	1	3	3	3	4	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69580	p53-Dependent G1/S DNA damage checkpoint	40	44	4	2	1	3	3	3	4	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69615	G1/S DNA Damage Checkpoints	42	46	4	2	1	3	3	3	4	0	0	29	46	4817	0.75975	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418346	Platelet homeostasis	33	43	4	2	1	3	3	2	4	0	0	29	43	4820	0.77354	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1442490	Collagen degradation	11	16	1	1	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8878159	Transcriptional regulation by RUNX3	49	54	4	2	1	3	3	3	4	0	0	29	54	4809	0.7241	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1433557	Signaling by SCF-KIT	17	23	1	1	1	1	1	1	1	1	1	28	22	4841	0.99205	0.12808	0.12808	4.35	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-9013407	RHOH GTPase cycle	15	20	1	1	0	1	1	1	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110362	POLB-Dependent Long Patch Base Excision Repair	4	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	12	12	2	1	0	2	2	2	2	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196299	Beta-catenin phosphorylation cascade	13	13	1	0	0	0	0	0	1	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6807878	COPI-mediated anterograde transport	46	51	2	2	2	1	1	1	2	1	1	28	50	4813	0.96383	0.26273	0.26273	1.96	394141	dctn2	ENSDARG00000031388		30.7771	30.7771	30.7771		30.7771		20.0664	20.0664	20.0664		20.0664		47.2048	47.2048	47.2048		47.20479999999999						30.7771	20.0664	47.2048	0	1	0															1	394141	ENSDARG00000031388	30.7771	30.7771		20.0664	20.0664		47.2048	47.2048		30.7771	20.0664	47.2048	0						Linear,1(1)	2.3439059257507324	2.3439059257507324	2.3439059257507324	2.3439059257507324	0.0	2.3439059257507324	30.7771	30.7771	20.0664	20.0664	47.2048	47.2048	DOWN	0.0	1.0	0.0	
R-DRE-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	4	5	1	1	1	0	0	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	7	8	1	1	1	0	0	0	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174143	APC/C-mediated degradation of cell cycle proteins	55	61	6	4	2	5	5	5	6	1	1	28	60	4803	0.94994	0.30576	0.30576	1.64	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-174154	APC/C:Cdc20 mediated degradation of Securin	47	52	6	4	2	5	5	5	6	1	1	28	51	4812	0.96252	0.26714	0.26714	1.92	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	49	54	6	4	2	5	5	5	6	1	1	28	53	4810	0.95985	0.2759	0.2759	1.85	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	50	56	6	4	2	5	5	5	6	1	1	28	55	4808	0.9571	0.28455	0.28455	1.79	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	50	56	6	4	2	5	5	5	6	1	1	28	55	4808	0.9571	0.28455	0.28455	1.79	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-453276	Regulation of mitotic cell cycle	55	61	6	4	2	5	5	5	6	1	1	28	60	4803	0.94994	0.30576	0.30576	1.64	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	15	16	2	2	1	2	2	2	2	1	1	28	15	4848	0.99613	0.090879	0.090879	6.25	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003		0.0	69.6462			69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	15	16	2	2	1	2	2	2	2	1	1	28	15	4848	0.99613	0.090879	0.090879	6.25	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003		0.0	69.6462			69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-174048	APC/C:Cdc20 mediated degradation of Cyclin B	18	19	2	2	1	2	2	2	2	1	1	28	18	4845	0.99455	0.10701	0.10701	5.26	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003		0.0	69.6462			69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-174084	Autodegradation of Cdh1 by Cdh1:APC/C	46	49	5	3	2	4	4	4	5	1	1	28	48	4815	0.9664	0.25382	0.25382	2.04	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	49	54	6	4	2	5	5	5	6	1	1	28	53	4810	0.95985	0.2759	0.2759	1.85	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	16	17	2	2	1	2	2	2	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003		0.0	69.6462			69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-176408	Regulation of APC/C activators between G1/S and early anaphase	19	21	2	2	1	2	2	2	2	1	1	28	20	4843	0.99335	0.11761	0.11761	4.76	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-176412	Phosphorylation of the APC/C	14	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003		0.0	69.6462			69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-179409	APC-Cdc20 mediated degradation of Nek2A	19	20	2	2	1	2	2	2	2	1	1	28	19	4844	0.99397	0.11232	0.11232	5.0	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003		0.0	69.6462			69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	50	55	6	4	2	5	5	5	6	1	1	28	54	4809	0.95848	0.28024	0.28024	1.82	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-69017	CDK-mediated phosphorylation and removal of Cdc6	49	54	5	3	2	4	4	4	5	1	1	28	53	4810	0.95985	0.2759	0.2759	1.85	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-69052	Switching of origins to a post-replicative state	60	67	5	3	2	4	4	4	5	1	1	28	66	4797	0.94081	0.3304	0.3304	1.49	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-69239	Synthesis of DNA	74	81	6	3	2	5	5	5	6	1	1	28	80	4783	0.91753	0.38467	0.38467	1.23	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-69306	DNA Replication	77	87	6	3	2	5	5	5	6	1	1	28	86	4777	0.9068	0.4066	0.4066	1.15	550576	anapc16	ENSDARG00000013822		69.6462	69.6462	69.6462		69.6462		31.7026	31.7026	31.7026		31.7026		153.003	153.003	153.003		153.003						69.6462	31.7026	153.003	0	1	0															1	550576	ENSDARG00000013822	69.6462	69.6462		31.7026	31.7026		153.003	153.003		69.6462	31.7026	153.003	0						Linear,1(1)	1.7563469409942627	1.7563469409942627	1.7563469409942627	1.7563469409942627	0.0	1.7563469409942627	69.6462	69.6462	31.7026	31.7026	153.003	153.003	DOWN	0.0	1.0	0.0	
R-DRE-196836	Vitamin C (ascorbate) metabolism	4	5	1	1	1	1	1	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8963691	Phenylalanine and tyrosine metabolism	6	7	1	1	1	0	0	0	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8964208	Phenylalanine metabolism	4	5	1	1	1	0	0	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1660662	Glycosphingolipid metabolism	14	23	1	1	0	1	1	1	1	0	0	29	23	4840	0.87192	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2024096	HS-GAG degradation	5	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013422	RHOBTB1 GTPase cycle	8	10	1	1	1	1	1	0	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9706574	RHOBTB GTPase Cycle	14	16	1	1	1	1	1	0	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654706	FRS-mediated FGFR3 signaling	5	11	1	1	1	1	1	1	1	1	1	28	10	4853	0.99819	0.063373	0.063373	9.09	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654708	Downstream signaling of activated FGFR3	8	15	2	2	1	2	2	2	2	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654741	Signaling by FGFR3	20	27	3	2	1	2	2	2	3	1	1	28	26	4837	0.98913	0.14868	0.14868	3.7	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-432722	Golgi Associated Vesicle Biogenesis	23	27	2	1	0	2	2	2	2	0	0	29	27	4836	0.85132	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-937039	IRAK1 recruits IKK complex	10	13	2	1	1	1	1	0	2	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	10	13	2	1	1	1	1	0	2	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1538133	G0 and Early G1	10	12	1	1	1	1	1	0	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201451	Signaling by BMP	14	17	1	0	0	1	1	0	1	0	0	29	17	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418885	DCC mediated attractive signaling	9	10	1	0	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-75109	Triglyceride biosynthesis	5	6	1	1	0	0	0	0	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8979227	Triglyceride metabolism	12	13	2	2	1	1	1	1	2	1	1	28	12	4851	0.99746	0.07447	0.07447	7.69	554095	fabp1b.1	ENSDARG00000059227		60.5176	60.5176	60.5176		60.5176		30.1468	30.1468	30.1468		30.1468		121.485	121.485	121.485		121.485		0.0	60.5176			60.5176	30.1468	121.485	1	0	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	0															0						Linear,1(1)	1.5967966318130493	1.5967966318130493	1.5967966318130493	1.5967966318130493	0.0	1.5967966318130493	60.5176	60.5176	30.1468	30.1468	121.485	121.485	UP	1.0	0.0	0.0	
R-DRE-5223345	Miscellaneous transport and binding events	12	14	1	1	1	0	0	0	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1168372	Downstream signaling events of B Cell Receptor (BCR)	40	46	5	3	2	4	4	4	5	1	1	28	45	4818	0.9701	0.24025	0.24025	2.17	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-2468052	Establishment of Sister Chromatid Cohesion	8	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68827	CDT1 association with the CDC6:ORC:origin complex	37	42	4	2	1	3	3	3	4	0	0	29	42	4821	0.7782	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68867	Assembly of the pre-replicative complex	41	47	4	2	1	3	3	3	4	0	0	29	47	4816	0.7552	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68949	Orc1 removal from chromatin	45	51	4	2	1	3	3	3	4	0	0	29	51	4812	0.73727	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68962	Activation of the pre-replicative complex	18	22	1	0	0	1	1	1	1	0	0	29	22	4841	0.87714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69002	DNA Replication Pre-Initiation	52	60	5	2	1	4	4	4	5	0	0	29	60	4803	0.69843	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5685942	HDR through Homologous Recombination (HRR)	29	37	1	0	0	1	1	1	1	0	0	29	37	4826	0.80187	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5621575	CD209 (DC-SIGN) signaling	3	6	1	1	1	1	1	1	1	1	1	28	5	4858	0.9995	0.035063	0.035063	16.67	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-4608870	Asymmetric localization of PCP proteins	37	43	4	2	1	3	3	3	4	0	0	29	43	4820	0.77354	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1169091	Activation of NF-kappaB in B cells	33	38	4	2	1	3	3	3	4	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1234174	Cellular response to hypoxia	43	50	5	2	1	4	4	3	5	0	0	29	50	4813	0.74172	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	41	48	5	2	1	4	4	3	5	0	0	29	48	4815	0.75068	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-349425	Autodegradation of the E3 ubiquitin ligase COP1	35	38	4	2	1	3	3	3	4	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4641257	Degradation of AXIN	36	39	4	2	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5358346	Hedgehog ligand biogenesis	39	45	4	2	1	3	3	3	4	0	0	29	45	4818	0.76432	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5610780	Degradation of GLI1 by the proteasome	36	39	4	2	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5610785	GLI3 is processed to GLI3R by the proteasome	41	44	4	2	1	3	3	3	4	0	0	29	44	4819	0.76892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5610787	Hedgehog 'off' state	52	61	4	2	1	3	3	3	4	0	0	29	61	4802	0.69424	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69541	Stabilization of p53	36	39	4	2	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	35	38	4	2	1	3	3	3	4	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69610	p53-Independent DNA Damage Response	35	38	4	2	1	3	3	3	4	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69613	p53-Independent G1/S DNA damage checkpoint	35	38	4	2	1	3	3	3	4	0	0	29	38	4825	0.79708	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-75815	Ubiquitin-dependent degradation of Cyclin D	34	37	4	2	1	3	3	3	4	0	0	29	37	4826	0.80187	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	36	40	4	2	1	3	3	3	4	0	0	29	40	4823	0.78759	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8941858	Regulation of RUNX3 expression and activity	35	37	4	2	1	3	3	3	4	0	0	29	37	4826	0.80187	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73762	RNA Polymerase I Transcription Initiation	29	29	1	1	1	1	1	1	1	1	1	28	28	4835	0.98752	0.1588	0.1588	3.45	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-73863	RNA Polymerase I Transcription Termination	22	22	1	1	1	1	1	1	1	1	1	28	21	4842	0.99272	0.12286	0.12286	4.55	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866						50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-74158	RNA Polymerase III Transcription	17	19	1	1	1	1	1	1	1	1	1	28	18	4845	0.99455	0.10701	0.10701	5.26	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866		0.0	50.7841			50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-76046	RNA Polymerase III Transcription Initiation	17	19	1	1	1	1	1	1	1	1	1	28	18	4845	0.99455	0.10701	0.10701	5.26	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866		0.0	50.7841			50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	14	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866		0.0	50.7841			50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	14	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866		0.0	50.7841			50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	13	15	1	1	1	1	1	1	1	1	1	28	14	4849	0.9966	0.085441	0.085441	6.67	445170	polr2eb	ENSDARG00000026183		50.7841	50.7841	50.7841		50.78410000000001		27.7952	27.7952	27.7952		27.7952		92.7866	92.7866	92.7866		92.7866		0.0	50.7841			50.7841	27.7952	92.7866	1	0	1	445170	ENSDARG00000026183	50.7841	50.7841		27.7952	27.7952		92.7866	92.7866		50.7841	27.7952	92.7866	0															0						Linear,1(1)	1.9996205568313599	1.9996205568313599	1.9996205568313599	1.9996205568313599	0.0	1.9996205568313599	50.7841	50.7841	27.7952	27.7952	92.7866	92.7866	UP	1.0	0.0	0.0	
R-DRE-110314	Recognition of DNA damage by PCNA-containing replication complex	15	16	1	0	0	1	1	1	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5651801	PCNA-Dependent Long Patch Base Excision Repair	9	9	1	0	0	1	1	1	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	11	12	1	0	0	1	1	1	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68952	DNA replication initiation	6	6	1	0	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77289	Mitochondrial Fatty Acid Beta-Oxidation	14	16	1	0	0	0	0	0	1	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2161522	Abacavir transport and metabolism	5	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2161541	Abacavir metabolism	5	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-74259	Purine catabolism	9	12	1	1	1	1	1	1	1	1	1	28	11	4852	0.99784	0.068937	0.068937	8.33	561810	dnph1	ENSDARG00000075730		92.0486	92.0486	92.0486		92.0486		33.5239	33.5239	33.5239		33.5239		252.744	252.744	252.744		252.74399999999997		0.0	92.0486			92.0486	33.5239	252.744	0	1	0															1	561810	ENSDARG00000075730	92.0486	92.0486		33.5239	33.5239		252.744	252.744		92.0486	33.5239	252.744	0						Linear,1(1)	2.877150297164917	2.877150297164917	2.877150297164917	2.877150297164917	0.0	2.877150297164917	92.0486	92.0486	33.5239	33.5239	252.744	252.744	DOWN	0.0	1.0	0.0	
R-DRE-1592230	Mitochondrial biogenesis	22	22	2	2	2	2	2	2	2	2	2	27	20	4843	0.99973	0.0072836	0.0072836	9.09	436914;436878	acss2;sirt5	ENSDARG00000037781;ENSDARG00000039684		60.655199999999994	60.655199999999994	37.9274	32.14196300290325	46.77464490586926	25.451250779433295	28.2969	28.2969	23.3493	6.996963021197114	25.275250989373315	5.540466228861739	135.37305	135.37305	61.6071	104.32080693133561	90.321952531442	82.60525402516457	0.5	60.655199999999994			37.9274;83.383	23.3493;33.2445	61.6071;209.139	2	0	2	436914;436878	ENSDARG00000037781;ENSDARG00000039684	60.655199999999994	60.655199999999994	32.14196300290325	28.2969	28.2969	6.996963021197114	135.37305	135.37305	104.32080693133561	37.9274;83.383	23.3493;33.2445	61.6071;209.139	0															0						Linear,2(1)	3.2406218957722306	7.8244242668151855	1.7204608917236328	6.103963375091553	3.0996043313375274	3.9122121334075928	16.108712000000004	105.20168799999999	18.599604	37.994196	-9.208211999999975	279.95431199999996	UP	1.0	0.0	0.0	
R-DRE-2151201	Transcriptional activation of mitochondrial biogenesis	8	8	2	2	2	2	2	2	2	2	2	27	6	4857	0.99999	9.2945E-4	9.2945E-4	25.0	436914;436878	acss2;sirt5	ENSDARG00000037781;ENSDARG00000039684		60.655199999999994	60.655199999999994	37.9274	32.14196300290325	46.77464490586926	25.451250779433295	28.2969	28.2969	23.3493	6.996963021197114	25.275250989373315	5.540466228861739	135.37305	135.37305	61.6071	104.32080693133561	90.321952531442	82.60525402516457	0.0	37.9274	0.0	37.9274	37.9274;83.383	23.3493;33.2445	61.6071;209.139	2	0	2	436914;436878	ENSDARG00000037781;ENSDARG00000039684	60.655199999999994	60.655199999999994	32.14196300290325	28.2969	28.2969	6.996963021197114	135.37305	135.37305	104.32080693133561	37.9274;83.383	23.3493;33.2445	61.6071;209.139	0															0						Linear,2(1)	3.2406218957722306	7.8244242668151855	1.7204608917236328	6.103963375091553	3.0996043313375274	3.9122121334075928	16.108712000000004	105.20168799999999	18.599604	37.994196	-9.208211999999975	279.95431199999996	UP	1.0	0.0	0.0	
R-DRE-5685939	HDR through MMEJ (alt-NHEJ)	8	9	1	1	0	1	1	1	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5620920	Cargo trafficking to the periciliary membrane	17	21	2	1	1	1	1	0	2	0	0	29	21	4842	0.88239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	22	23	1	0	0	1	1	1	1	0	0	29	23	4840	0.87192	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2514856	The phototransduction cascade	17	20	3	3	3	1	1	1	3	1	1	28	19	4844	0.99397	0.11232	0.11232	5.0	570333	rcvrna	ENSDARG00000052223		57.3841	57.3841	57.3841		57.3841		29.4448	29.4448	29.4448		29.444800000000004		111.834	111.834	111.834		111.834		0.0	57.3841			57.3841	29.4448	111.834	1	0	1	570333	ENSDARG00000052223	57.3841	57.3841		29.4448	29.4448		111.834	111.834		57.3841	29.4448	111.834	0															0						Linear,1(1)	2.16167950630188	2.16167950630188	2.16167950630188	2.16167950630188	0.0	2.16167950630188	57.3841	57.3841	29.4448	29.4448	111.834	111.834	UP	1.0	0.0	0.0	
R-DRE-2514859	Inactivation, recovery and regulation of the phototransduction cascade	16	19	3	3	3	1	1	1	3	1	1	28	18	4845	0.99455	0.10701	0.10701	5.26	570333	rcvrna	ENSDARG00000052223		57.3841	57.3841	57.3841		57.3841		29.4448	29.4448	29.4448		29.444800000000004		111.834	111.834	111.834		111.834		0.0	57.3841			57.3841	29.4448	111.834	1	0	1	570333	ENSDARG00000052223	57.3841	57.3841		29.4448	29.4448		111.834	111.834		57.3841	29.4448	111.834	0															0						Linear,1(1)	2.16167950630188	2.16167950630188	2.16167950630188	2.16167950630188	0.0	2.16167950630188	57.3841	57.3841	29.4448	29.4448	111.834	111.834	UP	1.0	0.0	0.0	
R-DRE-4570464	SUMOylation of RNA binding proteins	26	26	3	1	1	1	1	1	3	1	1	28	25	4838	0.9899	0.14357	0.14357	3.85	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	21	26	1	1	1	0	0	0	1	0	0	29	26	4837	0.85643	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	14	15	3	2	1	2	2	2	3	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5673000	RAF activation	21	23	2	1	1	1	1	1	2	1	1	28	22	4841	0.99205	0.12808	0.12808	4.35	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846						41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-9024446	NR1H2 and NR1H3-mediated signaling	7	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	7	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9623433	NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis	4	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2470946	Cohesin Loading onto Chromatin	6	7	1	1	1	0	0	0	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68884	Mitotic Telophase/Cytokinesis	8	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	6	10	1	1	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-180024	DARPP-32 events	15	16	2	0	0	0	0	0	2	0	0	29	16	4847	0.90912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2022923	Dermatan sulfate biosynthesis	3	8	1	1	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5627123	RHO GTPases activate PAKs	10	10	1	0	0	1	1	0	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-202424	Downstream TCR signaling	11	13	2	1	1	1	1	0	2	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450302	activated TAK1 mediates p38 MAPK activation	13	15	2	1	1	1	1	0	2	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-937042	IRAK2 mediated activation of TAK1 complex	7	8	1	1	1	0	0	0	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70895	Branched-chain amino acid catabolism	12	12	3	1	0	1	1	1	3	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	4	4	1	0	0	0	0	0	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	2	2	1	0	0	0	0	0	1	0	0	29	2	4861	0.98818	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	3	3	1	0	0	0	0	0	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	3	3	1	0	0	0	0	0	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	3	3	1	0	0	0	0	0	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	3	3	1	0	0	0	0	0	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-169893	Prolonged ERK activation events	10	12	1	1	0	1	1	1	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-187687	Signalling to ERKs	14	17	2	2	1	2	2	2	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-70263	Gluconeogenesis	22	22	1	1	0	0	0	0	1	0	0	29	22	4841	0.87714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-264876	Insulin processing	4	6	2	2	2	0	0	0	2	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5620916	VxPx cargo-targeting to cilium	6	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1236394	Signaling by ERBB4	16	19	1	1	1	1	1	1	1	1	1	28	18	4845	0.99455	0.10701	0.10701	5.26	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-1295596	Spry regulation of FGF signaling	13	13	1	0	0	0	0	0	1	0	0	29	13	4850	0.92553	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193639	p75NTR signals via NF-kB	6	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-205043	NRIF signals cell death from the nucleus	8	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-209543	p75NTR recruits signalling complexes	6	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-209560	NF-kB is activated and signals survival	5	7	1	1	1	0	0	0	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173788	Downregulation of TGF-beta receptor signaling	7	8	1	0	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173789	TGF-beta receptor signaling activates SMADs	13	14	1	0	0	1	1	1	1	0	0	29	14	4849	0.92003	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654732	Negative regulation of FGFR3 signaling	15	20	1	0	0	0	0	0	1	0	0	29	20	4843	0.88768	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	20	25	1	1	1	1	1	0	1	0	0	29	25	4838	0.86156	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-420092	Glucagon-type ligand receptors	17	23	1	1	1	1	1	0	1	0	0	29	23	4840	0.87192	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1169092	Activation of RAS in B cells	2	2	1	1	1	1	1	1	1	1	1	28	1	4862	0.99997	0.011822	0.011822	50.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-392517	Rap1 signalling	9	10	1	0	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	7	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5362517	Signaling by Retinoic Acid	29	32	2	1	0	1	1	1	2	0	0	29	32	4831	0.82624	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5365859	RA biosynthesis pathway	11	12	1	1	0	1	1	1	1	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159227	Transport of the SLBP independent Mature mRNA	17	17	2	1	1	1	1	1	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925		0.0	84.2679			84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-159230	Transport of the SLBP Dependant Mature mRNA	17	17	2	1	1	1	1	1	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925		0.0	84.2679			84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-159231	Transport of Mature mRNA Derived from an Intronless Transcript	17	17	2	1	1	1	1	1	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925		0.0	84.2679			84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	17	17	2	1	1	1	1	1	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925		0.0	84.2679			84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-8939902	Regulation of RUNX2 expression and activity	36	39	4	2	1	3	3	3	4	0	0	29	39	4824	0.79232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9010553	Regulation of expression of SLITs and ROBOs	5	5	1	0	0	1	1	1	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4085377	SUMOylation of SUMOylation proteins	21	22	3	1	1	1	1	1	3	1	1	28	21	4842	0.99272	0.12286	0.12286	4.55	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-163560	Triglyceride catabolism	7	7	1	1	1	1	1	1	1	1	1	28	6	4857	0.9993	0.04079	0.04079	14.29	554095	fabp1b.1	ENSDARG00000059227		60.5176	60.5176	60.5176		60.5176		30.1468	30.1468	30.1468		30.1468		121.485	121.485	121.485		121.485		0.0	60.5176	0.0	60.5176	60.5176	30.1468	121.485	1	0	1	554095	ENSDARG00000059227	60.5176	60.5176		30.1468	30.1468		121.485	121.485		60.5176	30.1468	121.485	0															0						Linear,1(1)	1.5967966318130493	1.5967966318130493	1.5967966318130493	1.5967966318130493	0.0	1.5967966318130493	60.5176	60.5176	30.1468	30.1468	121.485	121.485	UP	1.0	0.0	0.0	
R-DRE-392154	Nitric oxide stimulates guanylate cyclase	3	7	1	0	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418457	cGMP effects	2	4	1	0	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	10	15	1	1	0	1	1	1	1	0	0	29	15	4848	0.91456	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	2	2	1	1	0	1	1	1	1	0	0	29	2	4861	0.98818	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9617828	FOXO-mediated transcription of cell cycle genes	6	6	2	1	1	1	1	1	2	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-167044	Signalling to RAS	4	5	1	1	1	1	1	1	1	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-171007	p38MAPK events	4	5	1	1	1	1	1	1	1	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-191273	Cholesterol biosynthesis	8	9	2	2	0	2	2	2	2	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3232118	SUMOylation of transcription factors	12	18	2	1	0	1	1	1	2	0	0	29	18	4845	0.89834	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2980766	Nuclear Envelope Breakdown	21	21	3	2	1	1	1	1	3	1	1	28	20	4843	0.99335	0.11761	0.11761	4.76	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-3301854	Nuclear Pore Complex (NPC) Disassembly	17	17	2	1	1	1	1	1	2	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925		0.0	84.2679			84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-4615885	SUMOylation of DNA replication proteins	28	29	3	1	1	1	1	1	3	1	1	28	28	4835	0.98752	0.1588	0.1588	3.45	337461	nup35	ENSDARG00000012222		84.2679	84.2679	84.2679		84.2679		33.1942	33.1942	33.1942		33.1942		213.925	213.925	213.925		213.925						84.2679	33.1942	213.925	0	1	0															1	337461	ENSDARG00000012222	84.2679	84.2679		33.1942	33.1942		213.925	213.925		84.2679	33.1942	213.925	0						Linear,1(1)	13.28191661834717	13.281916618347168	13.281916618347168	13.281916618347168	0.0	13.281916618347168	84.2679	84.2679	33.1942	33.1942	213.925	213.925	DOWN	0.0	1.0	0.0	
R-DRE-5626978	TNFR1-mediated ceramide production	3	5	1	1	1	1	1	1	1	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	550506	nsmaf	ENSDARG00000051920		40.6531	40.6531	40.6531		40.6531		24.4822	24.4822	24.4822		24.482199999999995		67.5052	67.5052	67.5052		67.5052		0.0	40.6531	0.0	40.6531	40.6531	24.4822	67.5052	0	1	0															1	550506	ENSDARG00000051920	40.6531	40.6531		24.4822	24.4822		67.5052	67.5052		40.6531	24.4822	67.5052	0						Linear,1(1)	11.86266231536865	11.862662315368652	11.862662315368652	11.862662315368652	0.0	11.862662315368652	40.6531	40.6531	24.4822	24.4822	67.5052	67.5052	DOWN	0.0	1.0	0.0	
R-DRE-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	6	7	1	1	0	1	1	1	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9603798	Class I peroxisomal membrane protein import	9	13	1	1	1	1	1	1	1	1	1	28	12	4851	0.99746	0.07447	0.07447	7.69	559933	pex14	ENSDARG00000028322		58.814	58.814	58.814		58.814		29.9372	29.9372	29.9372		29.9372		115.545	115.545	115.545		115.545		0.0	58.814			58.814	29.9372	115.545	1	0	1	559933	ENSDARG00000028322	58.814	58.814		29.9372	29.9372		115.545	115.545		58.814	29.9372	115.545	0															0						Linear,1(1)	2.1846325397491455	2.1846325397491455	2.1846325397491455	2.1846325397491455	0.0	2.1846325397491455	58.814	58.814	29.9372	29.9372	115.545	115.545	UP	1.0	0.0	0.0	
R-DRE-389599	Alpha-oxidation of phytanate	2	3	1	1	0	1	1	1	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1181150	Signaling by NODAL	3	3	2	1	1	1	1	1	2	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9617629	Regulation of FOXO transcriptional activity by acetylation	6	6	1	1	1	0	0	0	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5624138	Trafficking of myristoylated proteins to the cilium	4	4	1	0	0	1	1	0	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	7	8	1	1	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425410	Metal ion SLC transporters	7	9	1	1	1	0	0	0	1	0	0	29	9	4854	0.94785	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-435354	Zinc transporters	4	5	1	1	1	0	0	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163359	Glucagon signaling in metabolic regulation	7	8	1	1	1	1	1	0	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1250347	SHC1 events in ERBB4 signaling	6	6	1	1	1	1	1	1	1	1	1	28	5	4858	0.9995	0.035063	0.035063	16.67	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-1963640	GRB2 events in ERBB2 signaling	5	5	1	1	1	1	1	1	1	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-1963642	PI3K events in ERBB2 signaling	5	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-176417	Phosphorylation of Emi1	4	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-549132	Organic cation/anion/zwitterion transport	2	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-561048	Organic anion transport	1	1	1	1	0	1	1	1	1	0	0	29	1	4862	0.99407	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5654710	PI-3K cascade:FGFR3	5	11	1	1	0	1	1	1	1	0	0	29	11	4852	0.93663	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4419969	Depolymerisation of the Nuclear Lamina	5	5	1	1	0	0	0	0	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418359	Reduction of cytosolic Ca++ levels	4	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418360	Platelet calcium homeostasis	5	8	1	1	0	1	1	1	1	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-170984	ARMS-mediated activation	3	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5676934	Protein repair	6	6	1	1	0	1	1	1	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-74182	Ketone body metabolism	4	5	1	1	0	1	1	1	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77111	Synthesis of Ketone Bodies	4	5	1	1	0	1	1	1	1	0	0	29	5	4858	0.9707	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-156842	Eukaryotic Translation Elongation	3	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-426048	Arachidonate production from DAG	2	4	1	1	1	1	1	1	1	1	1	28	3	4860	0.9998	0.023509	0.023509	25.0	767657	abhd12	ENSDARG00000071004		84.515	84.515	84.515		84.515		33.067	33.067	33.067		33.067		216.009	216.009	216.009		216.009		0.0	84.515	0.0	84.515	84.515	33.067	216.009	0	1	0															1	767657	ENSDARG00000071004	84.515	84.515		33.067	33.067		216.009	216.009		84.515	33.067	216.009	0						Linear,1(1)	2.24393630027771	2.24393630027771	2.24393630027771	2.24393630027771	0.0	2.24393630027771	84.515	84.515	33.067	33.067	216.009	216.009	DOWN	0.0	1.0	0.0	
R-DRE-434313	Intracellular metabolism of fatty acids regulates insulin secretion	2	2	1	1	0	1	1	1	1	0	0	29	2	4861	0.98818	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2428933	SHC-related events triggered by IGF1R	2	3	1	1	0	1	1	1	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196791	Vitamin D (calciferol) metabolism	6	6	1	0	0	0	0	0	1	0	0	29	6	4857	0.96494	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-189451	Heme biosynthesis	5	5	2	2	1	2	2	2	2	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	553384	cox10	ENSDARG00000034309		57.335	57.335	57.335		57.335		29.5537	29.5537	29.5537		29.5537		111.232	111.232	111.232		111.232		0.0	57.335	0.0	57.335	57.335	29.5537	111.232	0	1	0															1	553384	ENSDARG00000034309	57.335	57.335		29.5537	29.5537		111.232	111.232		57.335	29.5537	111.232	0						Linear,1(1)	2.0910441875457764	2.0910441875457764	2.0910441875457764	2.0910441875457764	0.0	2.0910441875457764	57.335	57.335	29.5537	29.5537	111.232	111.232	DOWN	0.0	1.0	0.0	
R-DRE-375165	NCAM signaling for neurite out-growth	15	17	1	1	1	1	1	1	1	1	1	28	16	4847	0.99563	0.096286	0.096286	5.88	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759			41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-9634635	Estrogen-stimulated signaling through PRKCZ	3	3	1	1	1	1	1	1	1	1	1	28	2	4861	0.9999	0.017683	0.017683	33.33	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-2995383	Initiation of Nuclear Envelope (NE) Reformation	10	10	1	0	0	1	1	1	1	0	0	29	10	4853	0.94222	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	8	8	2	0	0	1	1	1	2	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-113510	E2F mediated regulation of DNA replication	8	8	2	0	0	1	1	1	2	0	0	29	8	4855	0.95352	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-881907	Gastrin-CREB signalling pathway via PKC and MAPK	5	5	1	1	1	1	1	1	1	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-2485179	Activation of the phototransduction cascade	7	7	1	1	1	0	0	0	1	0	0	29	7	4856	0.95921	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8866376	Reelin signalling pathway	3	4	1	1	0	1	1	1	1	0	0	29	4	4859	0.97649	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2179392	EGFR Transactivation by Gastrin	5	5	1	1	1	1	1	1	1	1	1	28	4	4859	0.99966	0.029303	0.029303	20.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-5654704	SHC-mediated cascade:FGFR3	6	10	1	1	1	1	1	1	1	1	1	28	9	4854	0.99852	0.057776	0.057776	10.0	553656	hrasb	ENSDARG00000005651		41.759	41.759	41.759		41.759		24.7404	24.7404	24.7404		24.7404		70.4846	70.4846	70.4846		70.4846		0.0	41.759	0.0	41.759	41.759	24.7404	70.4846	1	0	1	553656	ENSDARG00000005651	41.759	41.759		24.7404	24.7404		70.4846	70.4846		41.759	24.7404	70.4846	0															0						Linear,1(1)	4.171412944793701	4.171412944793701	4.171412944793701	4.171412944793701	0.0	4.171412944793701	41.759	41.759	24.7404	24.7404	70.4846	70.4846	UP	1.0	0.0	0.0	
R-DRE-432142	Platelet sensitization by LDL	11	12	2	1	1	1	1	0	2	0	0	29	12	4851	0.93106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-435368	Zinc efflux and compartmentalization by the SLC30 family	3	3	1	1	1	0	0	0	1	0	0	29	3	4860	0.98232	1.0	1.0	0.0																														0	0	0															0															0																							
